<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">81926</article-id><article-id pub-id-type="doi">10.7554/eLife.81926</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Stem Cells and Regenerative Medicine</subject></subj-group></article-categories><title-group><article-title>Hepatic lipid overload triggers biliary epithelial cell activation via E2Fs</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-287393"><name><surname>Yildiz</surname><given-names>Ece</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-251972"><name><surname>El Alam</surname><given-names>Gaby</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-287394"><name><surname>Perino</surname><given-names>Alessia</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5434-3266</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-287395"><name><surname>Jalil</surname><given-names>Antoine</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-287396"><name><surname>Denechaud</surname><given-names>Pierre-Damien</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3502-4814</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="pa1">‡</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-274066"><name><surname>Huber</surname><given-names>Katharina</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-148361"><name><surname>Fajas</surname><given-names>Lluis</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1283-9503</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-10083"><name><surname>Auwerx</surname><given-names>Johan</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-287444"><name><surname>Sorrentino</surname><given-names>Giovanni</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="pa2">§</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-135955"><name><surname>Schoonjans</surname><given-names>Kristina</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1247-4265</contrib-id><email>kristina.schoonjans@epfl.ch</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02s376052</institution-id><institution>Laboratory of Metabolic Signaling, Institute of Bioengineering, Ecole Polytechnique Fédérale de Lausanne</institution></institution-wrap><addr-line><named-content content-type="city">Lausanne</named-content></addr-line><country>Switzerland</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02s376052</institution-id><institution>Laboratory of Integrative Systems Physiology, Institute of Bioengineering, Ecole Polytechnique Fédérale de Lausanne</institution></institution-wrap><addr-line><named-content content-type="city">Lausanne</named-content></addr-line><country>Switzerland</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/019whta54</institution-id><institution>Center for Integrative Genomics, Université de Lausanne</institution></institution-wrap><addr-line><named-content content-type="city">Lausanne</named-content></addr-line><country>Switzerland</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03fkrcm40</institution-id><institution>INSERM, Occitanie</institution></institution-wrap><addr-line><named-content content-type="city">Montpellier</named-content></addr-line><country>France</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Tontonoz</surname><given-names>Peter</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/046rm7j60</institution-id><institution>University of California, Los Angeles</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Isales</surname><given-names>Carlos</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/012mef835</institution-id><institution>Augusta University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn><fn fn-type="present-address" id="pa1"><label>‡</label><p>Institute of Metabolic and Cardiovascular Diseases (I2MC), UMR1297, INSERM, University of Toulouse, Toulouse, France</p></fn><fn fn-type="present-address" id="pa2"><label>§</label><p>Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>06</day><month>03</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>12</volume><elocation-id>e81926</elocation-id><history><date date-type="received" iso-8601-date="2022-07-16"><day>16</day><month>07</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2023-03-03"><day>03</day><month>03</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2022-07-28"><day>28</day><month>07</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.07.26.501569"/></event></pub-history><permissions><copyright-statement>© 2023, Yildiz et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Yildiz et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-81926-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-81926-figures-v2.pdf"/><abstract><p>During severe or chronic hepatic injury, biliary epithelial cells (BECs) undergo rapid activation into proliferating progenitors, a crucial step required to establish a regenerative process known as ductular reaction (DR). While DR is a hallmark of chronic liver diseases, including advanced stages of non-alcoholic fatty liver disease (NAFLD), the early events underlying BEC activation are largely unknown. Here, we demonstrate that BECs readily accumulate lipids during high-fat diet feeding in mice and upon fatty acid treatment in BEC-derived organoids. Lipid overload induces metabolic rewiring to support the conversion of adult cholangiocytes into reactive BECs. Mechanistically, we found that lipid overload activates the E2F transcription factors in BECs, which drive cell cycle progression while promoting glycolytic metabolism. These findings demonstrate that fat overload is sufficient to reprogram BECs into progenitor cells in the early stages of NAFLD and provide new insights into the mechanistic basis of this process, revealing unexpected connections between lipid metabolism, stemness, and regeneration.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>BECs</kwd><kwd>liver steatosis</kwd><kwd>BEC-organoids</kwd><kwd>BEC activation</kwd><kwd>cell cycle</kwd><kwd>glycolysis</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001703</institution-id><institution>École Polytechnique Fédérale de Lausanne</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Schoonjans</surname><given-names>Kristina</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007793</institution-id><institution>Kristian Gerhard Jebsen Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Schoonjans</surname><given-names>Kristina</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001711</institution-id><institution>Swiss National Science Foundation</institution></institution-wrap></funding-source><award-id>310030_189178</award-id><principal-award-recipient><name><surname>Schoonjans</surname><given-names>Kristina</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001711</institution-id><institution>Swiss National Science Foundation</institution></institution-wrap></funding-source><award-id>31003A_179435</award-id><principal-award-recipient><name><surname>Auwerx</surname><given-names>Johan</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution>AIRC Start-Up 2020</institution></institution-wrap></funding-source><award-id>24322</award-id><principal-award-recipient><name><surname>Sorrentino</surname><given-names>Giovanni</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Chronic fat overload triggers the conversion of quiescent biliary epithelial cells into proliferative progenitors through an E2F-dependent mechanism.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Under physiological conditions, the hepatic epithelium, composed of hepatocytes and BECs (or cholangiocytes), is non-proliferative. Yet upon injury, these two cell types are capable of rapidly changing their phenotype from quiescent to proliferative, contributing to the prompt restoration of damaged tissue (<xref ref-type="bibr" rid="bib23">Gadd et al., 2020</xref>; <xref ref-type="bibr" rid="bib39">Michalopoulos, 2014</xref>; <xref ref-type="bibr" rid="bib40">Miyajima et al., 2014</xref>; <xref ref-type="bibr" rid="bib63">Yanger and Stanger, 2011</xref>). However, in chronic liver injury, characterized by impaired hepatocyte replication, BECs weigh-in and serve as the cell source for regenerative cellular expansion through the DR process (<xref ref-type="bibr" rid="bib12">Choi et al., 2014</xref>; <xref ref-type="bibr" rid="bib16">Deng et al., 2018</xref>; <xref ref-type="bibr" rid="bib21">Español-Suñer et al., 2012</xref>; <xref ref-type="bibr" rid="bib27">Huch et al., 2013</xref>; <xref ref-type="bibr" rid="bib33">Lu et al., 2015</xref>; <xref ref-type="bibr" rid="bib46">Raven et al., 2017</xref>; <xref ref-type="bibr" rid="bib48">Rodrigo-Torres et al., 2014</xref>; <xref ref-type="bibr" rid="bib49">Russell et al., 2019</xref>).</p><p>The molecular basis by which BECs expand during the DR has been extensively studied in models of chemical biliary damage and portal fibrosis using the chemical 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC). Several signaling pathways involving YAP (<xref ref-type="bibr" rid="bib37">Meyer et al., 2020</xref>; <xref ref-type="bibr" rid="bib44">Pepe-Mooney et al., 2019</xref>; <xref ref-type="bibr" rid="bib45">Planas-Paz et al., 2019</xref>), mTORC1 (<xref ref-type="bibr" rid="bib45">Planas-Paz et al., 2019</xref>), TET1-mediated hydroxymethylation (<xref ref-type="bibr" rid="bib2">Aloia et al., 2019</xref>) and NCAM1 (<xref ref-type="bibr" rid="bib57">Tsuchiya et al., 2014</xref>) have been reported to drive this process. Importantly, DR has also been observed in late-stage NAFLD patients with fibrosis and portal inflammation (<xref ref-type="bibr" rid="bib22">Gadd et al., 2014</xref>; <xref ref-type="bibr" rid="bib52">Sato et al., 2019</xref>; <xref ref-type="bibr" rid="bib55">Sorrentino et al., 2005</xref>). NAFLD, one of the most common chronic diseases, initiates with increased lipid accumulation, a stage called steatosis (<xref ref-type="bibr" rid="bib43">Paschos and Paletas, 2009</xref>). This pathology progresses into inflammation and fibrosis that can cause cirrhosis and hepatocellular carcinoma, which are the most frequent liver transplantation indications (<xref ref-type="bibr" rid="bib10">Byrne and Targher, 2015</xref>). YAP has been found to be activated in BECs in fibrotic livers but not in steatosis (<xref ref-type="bibr" rid="bib34">Machado et al., 2015</xref>), suggesting that YAP activation is necessary to support DR in the late fibrotic NAFLD stages, and thus, leaving the early molecular mechanisms of BEC activation, which precede the onset of the DR, unexplored.</p><p>BEC-derived organoids (BEC-organoids) can be established from intrahepatic bile duct progenitors and can proliferate, representing a promising in vitro approach to study regenerative mechanisms and therapies (<xref ref-type="bibr" rid="bib28">Huch et al., 2015</xref>; <xref ref-type="bibr" rid="bib27">Huch et al., 2013</xref>; <xref ref-type="bibr" rid="bib31">Li et al., 2017</xref>; <xref ref-type="bibr" rid="bib42">Okabe et al., 2009</xref>; <xref ref-type="bibr" rid="bib54">Shin et al., 2011</xref>; <xref ref-type="bibr" rid="bib56">Sorrentino et al., 2020</xref>). These self-renewing bi-potent organoids express biliary progenitor markers and are capable of differentiating into functional cholangiocyte- and hepatocyte-like lineages in specific differentiation media, which can engraft and repair bile ducts (<xref ref-type="bibr" rid="bib24">Hallett et al., 2022</xref>; <xref ref-type="bibr" rid="bib50">Sampaziotis et al., 2021</xref>) and improve liver function when transplanted into a mouse with liver disease (<xref ref-type="bibr" rid="bib28">Huch et al., 2015</xref>; <xref ref-type="bibr" rid="bib27">Huch et al., 2013</xref>; <xref ref-type="bibr" rid="bib31">Li et al., 2017</xref>).</p><p>Here, we used BEC-organoids and BECs isolated from chow diet (CD)- or high-fat diet (HFD)-fed mice and reported that they are affected by acute and chronic lipid overload, one of the initial steps of NAFLD. Lipid accumulation turns BECs from quiescent to proliferative cells, the earliest step of a DR, and promotes their expansion through the E2F transcription factors and the concomitant induction of glycolysis. These observations hence attribute a pivotal role to E2Fs, regulators of cell cycle and metabolism, in priming BEC activation during the early stages of NAFLD.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>BECs and BEC-organoids efficiently accumulate lipids in vivo and in vitro</title><p>To gain insight into how chronic lipid exposure, which induces liver steatosis, affects biliary progenitor function in vitro, we incubated single BECs with a mixture of oleic acid (OA) and palmitic acid (PA) (the fatty acid (FA) mix) – the two most abundant FAs found in livers of NAFLD patients (<xref ref-type="bibr" rid="bib4">Araya et al., 2004</xref>), for 7 days and allowed BEC-organoid formation (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Surprisingly, we observed that BEC-organoids efficiently accumulated lipid droplets in a dose-dependent manner (<xref ref-type="fig" rid="fig1">Figure 1B</xref>), and this process did not affect organoid viability (<xref ref-type="fig" rid="fig1">Figure 1C–D</xref>). To investigate how cells adapt their metabolism to lipid overload, we monitored the expression of several genes involved in lipid metabolism, including <italic>Scd1</italic> (de novo lipogenesis) (<xref ref-type="fig" rid="fig1">Figure 1E</xref>), <italic>Hmgcs2</italic> (ketogenesis), <italic>Pdk4</italic> (inhibition of pyruvate oxidation), and <italic>Aldh1a1</italic> (prevention against lipid peroxidation products) (<xref ref-type="fig" rid="fig1">Figure 1F</xref>) and found it to be affected by FA addition. These results suggest that BEC organoids actively reprogram their metabolism to cope with aberrant lipid overload.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Biliary epithelial cells (BECs) accumulate lipids.</title><p>(<bold>A</bold>) Schematic depicting fatty acid (FA) treatment of BEC-organoids in vitro. (<bold>B</bold>) Representative bright field and immunofluorescence (IF) images of lipids (BODIPY) in control (BSA) and FA-treated organoids. Close-up IF images were digitally zoomed in four times. n=3. (<bold>C</bold>) Cell-titer Glo and Caspase 3/7 activity measurement for viability and apoptosis detection relative to panel A. n=3. (<bold>D</bold>) Representative Nucgreen Dead 488 staining as composite images from bright field and fluorescent microscopy. n=3. (<bold>E–F</bold>) Quantification of <italic>Scd1</italic> (<bold>E</bold>) and <italic>Hmgcs2</italic>, <italic>Pdk4,</italic> and <italic>Aldh1a1</italic> (<bold>F</bold>) mRNA in control (BSA) and FA-treated organoids. n=3. (<bold>G</bold>) Schematic depicting chow diet (CD) and high-fat diet (HFD) feeding in vivo. (<bold>H</bold>) Representative images for co-staining of BODIPY and PANCK, relative to panel G. Close-up IF images were digitally zoomed in four times. n=3. (<bold>I</bold>) Representative quantitative plots of the percentage (left) and quantification (right) of BODIPY staining in EPCAM<sup>+</sup> BECs isolated from the liver of C57BL/6 J mice fed CD or HFD for 15 weeks. n=5. Data are shown as mean ± SEM. Absence of stars or ns, not significant (p&gt;0.05); *p&lt;0.05; **p&lt;0.01, ****p&lt;0.0001; one-way ANOVA with Dunnett’s test (<bold>C</bold>), Fisher’s LSD test (<bold>E, F</bold>), and unpaired, two-tailed Student’s t-test (<bold>I</bold>) were used. PV, portal vein. Scale bars, 200 μm (<bold>B</bold> - bright field), 100 μm (<bold>B</bold> - IF, <bold>D</bold>), and 10 μm (<bold>H</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81926-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Further characterization of lipid accumulation in biliary epithelial cells (BECs).</title><p>(<bold>A</bold>) Scheme depicting bovine serum albumin (BSA) or fatty acid (FA) mix treatment for already grown BEC-organoids for 4 days. (<bold>B</bold>) Representative bright field and immunofluorescence (IF) images of lipids (BODIPY) and ACTIN co-staining, relative to panel A. n=4. (<bold>C</bold>) Measurement of triglyceride concentration upon FA mix treatment relative to panel A, normalized by protein amount. n=4. (<bold>D</bold>) Cell-titer Glo measurement for viability detection relative to panel A. n=4. (<bold>E</bold>) Representative hematoxylin and eosin (H&amp;E) (top) and picrosirius red (bottom) staining of liver sections from C57BL/6 J mice fed chow diet (CD) or high-fat diet (HFD) for 15 weeks. The bar graph represents the body weight of the mice at the end of the experiment. n=10. (<bold>F</bold>) Representative Oil Red O staining, relative to panel E. n=8. (<bold>G–H</bold>) Representative cleaved caspase three staining (<bold>G</bold>) and quantification of apoptotic cells in bile ducts (<bold>H</bold>), relative to panel E. n=3. (<bold>I</bold>) Representative PANCK staining (left) and magnification (right), relative to panel E. n=5. (<bold>L</bold>) Flow cytometry gating strategy for analysis of BECs: individual cells were sequentially gated based on cell size (FSC-A versus SSC-A) and singlets. BECs were then selected based on EPCAM positivity after excluding leukocytes (CD45<sup>+</sup>), myeloid cells (CD11b<sup>+</sup>), and endothelial cells (CD31<sup>+</sup>), yielding a population of single CD45<sup>-</sup>/CD11b<sup>-</sup>/ CD31<sup>-</sup>/EPCAM<sup>+</sup> BECs. Data are shown as mean ± SEM. Absence of stars or ns, not significant (p&gt;0.05); *p&lt;0.05; ***p&lt;0.001; one-way ANOVA with Dunnet’s test (<bold>C, D</bold>) or unpaired, two-tailed Student’s t-test (<bold>E</bold>) were used. PV, portal vein. Arrowheads mark bile ducts. Scale bars, 100 μm (<bold>B, E, I</bold> - zoom out), 50 μm (<bold>G</bold> - IF), and 20 μm (<bold>F, G</bold> - bright field, <bold>I</bold> - zoom in).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81926-fig1-figsupp1-v2.tif"/></fig></fig-group><p>To determine whether the observed phenotype was preserved in fully formed organoids, we treated already established BEC-organoids with the FA mix for 4 days (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). In line with our previous observations, BODIPY staining (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>), and triglyceride (TG) quantification (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>) showed a pronounced increase in lipid accumulation after 4 days, without affecting cell viability (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>).</p><p>To assess whether chronic lipid exposure affects BECs in vivo, we fed C57BL/6 J mice for 15 weeks with CD or HFD (<xref ref-type="fig" rid="fig1">Figure 1G</xref>) and analyzed their bile ducts. As expected, HFD-fed mice gained weight and developed liver steatosis, but no apparent fibrosis (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E</xref>). Of note, HFD-feeding led to an accumulation of lipid droplets in the periportal zone (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1F</xref>) and within bile ducts, as reflected by the localization of BODIPY signal in PANCK (BEC marker) positive cells (<xref ref-type="fig" rid="fig1">Figure 1H</xref>), without inducing epithelial damage (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1G–I</xref>). Moreover, flow cytometry analysis of BECs stained with EPCAM, a pan-BEC marker (<xref ref-type="bibr" rid="bib2">Aloia et al., 2019</xref>; <xref ref-type="bibr" rid="bib44">Pepe-Mooney et al., 2019</xref>; <xref ref-type="bibr" rid="bib45">Planas-Paz et al., 2019</xref>) and BODIPY confirmed that these cells are able to store lipids upon HFD feeding (<xref ref-type="fig" rid="fig1">Figure 1I</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1L</xref>). Together, these in vitro and in vivo results demonstrate that BECs accumulate lipids upon chronic FA exposure, raising the question of the functional consequences of this previously unrecognized event on BEC behavior.</p></sec><sec id="s2-2"><title>HFD feeding promotes BEC activation and increases organoid formation capacity</title><p>To characterize in vivo the impact of chronic lipid overload on BECs at the molecular level, we isolated EPCAM<sup>+</sup> BECs from livers of CD/HFD-fed mice by fluorescence-activated cell sorting (FACS) (<xref ref-type="fig" rid="fig2">Figure 2A</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>) and performed RNA sequencing (RNA-seq). Analysis of these data revealed a diet-dependent clustering in Principal Component Analysis (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>), indicating that HFD feeding induces considerable transcriptional changes in BECs in vivo. Differential expression analysis further revealed a total of 495 significantly changed genes, 121 upregulated and 374 downregulated (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref> and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). At the same time, HFD promoted the upregulation of <italic>Ncam1</italic> (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D</xref>)<italic>,</italic> a well-established mediator of BEC activation. Consistent with the absence of fibrosis and biliary epithelial damage, canonical makers of the DR (<xref ref-type="bibr" rid="bib36">Manco et al., 2019</xref>; <xref ref-type="bibr" rid="bib52">Sato et al., 2019</xref>; <xref ref-type="bibr" rid="bib57">Tsuchiya et al., 2014</xref>) were not changed in EPCAM<sup>+</sup> BECs isolated from livers of HFD-fed mice (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1E</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>High-fat diet (HFD) feeding induces EPCAM<sup>+</sup> biliary epithelial cell (BEC) proliferation.</title><p>(<bold>A</bold>) Scheme depicting the isolation of EPCAM<sup>+</sup> BECs from CD- and HFD-fed mice by fluorescence-activated cell sorting (FACS). (<bold>B</bold>) Gene set enrichment analysis (GSEA) of Gene Ontology (GO) terms. Top 15 upregulated biological processes (BP), ordered by normalized enrichment score (NES). q-value: false discovery rate adjusted p-values. (<bold>C–F</bold>) Representative co-staining images (<bold>C, E</bold>) and quantification (<bold>D, F</bold>) of BECs stained for OPN and Ki67 (<bold>C–D</bold>), or OPN and EdU (<bold>E–F</bold>) in livers of CD/HFD-fed mice. n=10 for Ki67 and n=5 for EdU. (<bold>G</bold>) Representative quantitative plots of the percentage (left) and quantification (right) of EdU<sup>+</sup> EPCAM<sup>+</sup> BECs, relative to panel A. n=5. (<bold>H</bold>) Schematic depicting BEC-organoid formation in vitro from CD/HFD-fed mouse livers. (<bold>I</bold>) Images of organoid colonies formed 6 days after seeding and quantification of organoids per well. n=5. Violin graphs depict the distribution of data points i.e the width of the shaded area represents the proportion of data located there. Other data are shown as mean ± SEM. **p&lt;0.01; ****p&lt;0.0001; unpaired, two-tailed Student’s t-test was used. PV, portal vein. Arrowheads mark bile ducts. Scale bars, 20 μm (<bold>C, E</bold>), 200 μm (<bold>I</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81926-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>RNA-seq analysis of EPCAM<sup>+</sup> biliary epithelial cells (BECs) upon high-fat diet (HFD).</title><p>(<bold>A</bold>) Fluorescence-activated cell sorting (FACS) gating strategy for isolation of CD45<sup>−</sup>/CD11b<sup>−</sup>/CD31<sup>−</sup>/EPCAM<sup>+</sup> BECs: individual cells were sequentially gated based on cell size (FSC-A versus SSC-A) and singlets. BECs were then selected based on EPCAM positivity after excluding leukocytes (CD45<sup>+</sup>), myeloid cells (CD11b<sup>+</sup>), and endothelial cells (CD31<sup>+</sup>), yielding a population of single CD45<sup>-</sup>/CD11b<sup>-</sup>/ CD31<sup>-</sup>/EPCAM<sup>+</sup> BECs. (<bold>B</bold>) Principal component analysis (PCA) of mRNAs measured in EPCAM<sup>+</sup> BECs from livers of mice fed chow diet (CD) or high-fat diet (HFD) by RNA-seq. n=5 for CD, n=7 for HFD. (<bold>C</bold>) Volcano plot of HFD vs. CD differential analysis. Top 20 differentially expressed genes were labeled. Blue dots represent downregulated genes (log2(FC) &lt; –1 &amp; adj. p-value &lt;0.05). Red dots represent upregulated genes (log2(FC) &gt;1 &amp; adj. p-value &lt;0.05). Gray dots represent genes not changing significantly. (<bold>D–E</bold>) Box plots representing the differential gene expression of <italic>Ncam1</italic> (<bold>D</bold>) and well-established markers of the DR signature (<bold>E</bold>). n=5 for CD, n=7 for HFD. The Y-axis depicts log2(cpm +1) values. (<bold>F</bold>) Gene set enrichment analysis (GSEA) of KEGG terms. Top 15 enriched pathways (sorted by q-value). q-value: false discovery rate adjusted p-values. NES: normalized enrichment score. Data are summarized in boxplots. Absence of stars or ns, not significant (p&gt;0.05); **p&lt;0.01; unpaired, two-tailed Student’s t-test (<bold>D, E</bold>) was used.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81926-fig2-figsupp1-v2.tif"/></fig></fig-group><p>To further explore the transcriptional changes, we performed gene set enrichment analysis (GSEA) on Gene Ontology (GO) terms (<xref ref-type="fig" rid="fig2">Figure 2B</xref>) and KEGG (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1F</xref>) pathways and identified cell proliferation, the most prevalent early feature of BEC activation (<xref ref-type="bibr" rid="bib52">Sato et al., 2019</xref>) as the major process induced in these cells upon HFD feeding. Expansion of the reactive BECs requires detachment from their niche and invasion of the parenchyma toward the damaged hepatic area. This process is made possible by reorganizing the extracellular matrix (ECM) and reducing focal adhesion, effectively downregulated in EPCAM<sup>+</sup> BECs upon HFD (<xref ref-type="fig" rid="fig2">Figure 2B</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1F</xref>).</p><p>To validate the RNA-seq data, we monitored the activation of BECs in vivo by measuring the number of proliferating BECs in the portal region of the livers of mice fed either CD or HFD (<xref ref-type="fig" rid="fig2">Figure 2C–D</xref>). Of note, we found that HFD feeding was sufficient to induce a marked increase in the number of active BECs (i.e. Ki67<sup>+</sup>/OPN<sup>+</sup> cells- <xref ref-type="fig" rid="fig2">Figure 2C–D</xref>). Similar results were observed in two independent cohorts of mice challenged with HFD and injected with EdU either to track proliferating cells by immunofluorescence (<xref ref-type="fig" rid="fig2">Figure 2E–F</xref>) or to quantify by flow cytometry the amount of EPCAM<sup>+</sup>/EdU<sup>+</sup> BECs in the liver (<xref ref-type="fig" rid="fig2">Figure 2G</xref>), confirming that chronic lipid exposure stimulates the appearance of reactive BECs within the bile ducts.</p><p>The efficiency of BECs to generate organoids in vitro has been shown to mirror their activation status (<xref ref-type="bibr" rid="bib2">Aloia et al., 2019</xref>). To functionally assess the impact of lipid overload on this process, we measured the organoid-forming capacity of isolated BECs, as a read-out of their regenerative potential. To this aim, we quantified the organoid formation efficiency of BECs isolated from CD- and HFD-fed mouse livers (<xref ref-type="fig" rid="fig2">Figure 2H</xref>). Strikingly, we observed that HFD-derived BECs were significantly more efficient in generating organoids than their CD counterparts (<xref ref-type="fig" rid="fig2">Figure 2I</xref>). Altogether, these results demonstrate that HFD feeding is sufficient to induce, in vivo, the exit of BECs from a quiescent state and the acquisition of both proliferative and pro-regenerative features.</p></sec><sec id="s2-3"><title>HFD feeding initiates BEC activation via E2Fs</title><p>To understand whether the mechanisms underlying BEC activation upon HFD in vivo involve canonical processes by which BECs expand during the DR in chronically damaged livers, we compared the transcriptional profile of BECs upon HFD with those of DDC-activated BECs (<xref ref-type="bibr" rid="bib44">Pepe-Mooney et al., 2019</xref>; GSE125688). We identified the most pronounced changes shared between HFD and DDC samples by overlapping separate over-representation enrichment analyses (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). Cell division, mitosis, and chromosome segregation were the shared enriched pathways for upregulated genes in HFD and DDC samples (<xref ref-type="fig" rid="fig3">Figure 3A</xref>), while ECM organization was the shared enriched pathway for the downregulated genes in HFD and DDC conditions (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>). We concluded that the mechanisms of BEC activation induced by lipid overload partially overlap with those by which BECs expand during the DR with biliary epithelial damage.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>E2Fs are enriched in 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) and high-fat diet (HFD) datasets and mediate biliary epithelial cell (BEC) activation in vivo.</title><p>(<bold>A</bold>) Over-representation analysis results. Top 13 enriched biological processes (BP) upon HFD (own data) and DDC (GSE125688) treatment. q-value: false discovery rate adjusted p-values, counts: number of found genes within a given gene set. (<bold>B–C</bold>) Enriched transcription factors (TFs) of upregulated genes identified by over-representation analysis in HFD (own data) and DDC (GSE125688) treatment (<bold>B</bold>), and during the process of organoid formation from single BECs (Organoids vs. T0) (GSE123133) (<bold>C</bold>). Asterisk (*) marks TFs of the ‘TF_ZHAO’ gene set. (<bold>D</bold>) Schematic depicting in vivo E2F1 analysis. (<bold>E–F</bold>) Representative images of PANCK/Ki67 co-staining in livers of <italic>E2f1</italic><sup>+/+</sup> and <italic>E2f1</italic><sup>-/-</sup> mice fed with chow diet (CD) or HFD (<bold>E</bold>) and quantification of proliferative BECs in the livers of the indicated mice (<bold>F</bold>). For CD, n=5 for <italic>E2f1</italic><sup>+/+</sup> and <italic>E2f1</italic><sup>-/-</sup>. For HFD, n=7 for <italic>E2f1</italic><sup>+/+</sup>, and n=8 for <italic>E2f1</italic><sup>-/-</sup>. Violin graphs depict the distribution of data points i.e., the width of the shaded area represents the proportion of data located there. ns, not significant; **p&lt;0.01; two-way ANOVA with Tukey’s test was used. PV, portal vein. Arrowheads mark bile ducts. Scale bars, 20 μm (<bold>E</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81926-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Extended analysis of biliary epithelial cells (BECs) upon high-fat diet (HFD), 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC), during BEC-organoid formation and E2F1 silencing.</title><p>(<bold>A</bold>) Over-representation analysis results. Top 15 enriched biological processes (BP) upon HFD (own data) and DDC (GSE125688) treatment in BECs. q-value: false discovery rate adjusted p-values, counts: number of found genes within a given gene set. (<bold>B</bold>) Heatmap of E2F1-4 target genes from transcription factor (TF) gene sets. Genes with absolute fold change lower than 0.5 were not shown. FC = fold change. (<bold>C</bold>) GO over-representation analysis of upregulated biological processes (BP) during the process of organoid formation from single BECs (Organoids vs. T0) (GSE123133). (<bold>D</bold>) Quantification of <italic>E2f1</italic> mRNA in EPCAM<sup>+</sup> BECs from livers of C57BL/6 J HFD-fed mice. BECs were isolated and treated with a pool of siRNAs specific for <italic>E2f1</italic> or with Scrambled siRNA (control). n=3. (<bold>E</bold>) Proliferation kinetics over 6 days (expressed as FC over day 0), relative to D. n=15 for Scrambled, n=12 for <italic>E2f1</italic>. Data are shown as mean ± SEM. *p&lt;0.05; unpaired, two-tailed Student’s t-test (<bold>D</bold>), and mixed-effect analysis with Sidak’s (<bold>E</bold>), and were used.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81926-fig3-figsupp1-v2.tif"/></fig></fig-group><p>Of note, a more detailed analysis of DDC- and HFD-derived BECs, revealed the concomitant enrichment of four overlapping transcription factor (TF) gene sets, E2F1-4 (<xref ref-type="fig" rid="fig3">Figure 3B</xref>), and their target genes (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>), which have not been linked to BEC activation or DR previously. Moreover, we identified an enrichment of E2Fs (<xref ref-type="fig" rid="fig3">Figure 3C</xref> and <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>) and cell division pathway (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>) as the most upregulated genes in proliferating BEC-organoids, further corroborating the role of E2Fs in these two in vitro (<xref ref-type="bibr" rid="bib2">Aloia et al., 2019</xref>) and in vivo (<xref ref-type="bibr" rid="bib44">Pepe-Mooney et al., 2019</xref>) DR models.</p><p>E2Fs are a large family of TFs with complex functions in cell cycle progression, DNA replication, repair, and G2/M checkpoints (<xref ref-type="bibr" rid="bib17">Dimova and Dyson, 2005</xref>; <xref ref-type="bibr" rid="bib19">Dyson, 1998</xref>; <xref ref-type="bibr" rid="bib20">Dyson, 2016</xref>; <xref ref-type="bibr" rid="bib47">Ren et al., 2002</xref>). Therefore, we hypothesized that the activation of E2Fs might represent an early event in the process of BEC activation, which is necessary for exiting the quiescent state and promoting BEC expansion. To test this hypothesis, we focused on E2F1, as it was the most enriched TF in our analysis, and assessed its role in BECs by feeding <italic>E2f1</italic><sup>+/+</sup> and <italic>E2f1</italic><sup>-/-</sup> mice with HFD (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). Remarkably, <italic>E2f1</italic><sup>-/-</sup> mice were refractory to BEC activation induced by lipid overload upon HFD, as opposed to <italic>E2f1</italic><sup>+/+</sup> mice (<xref ref-type="fig" rid="fig3">Figure 3E–F</xref>). In addition, silencing of E2F1 in EPCAM<sup>+</sup> BECs from livers of C57BL/6 J HFD-fed mice (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D</xref>) reduced the capacity to form organoids in vitro (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E</xref>). These results demonstrate a previously unrecognized role of E2F1 in controlling BEC activation during HFD-induced hepatic steatosis in vivo and support a pivotal role of this transcription factor in controlling BEC expansion.</p></sec><sec id="s2-4"><title>E2Fs promote BEC expansion by upregulating glycolysis</title><p>The exit of terminally-differentiated cells from their quiescent state requires both energy and building block availability to support cell proliferation. Proliferative cells, therefore, reprogram their glucose metabolism to meet their increased need for biomass and energy (<xref ref-type="bibr" rid="bib58">Vander Heiden et al., 2009</xref>). Supporting this notion, our interrogation of in vitro BEC-organoid formation dataset (<xref ref-type="bibr" rid="bib2">Aloia et al., 2019</xref>) revealed the enrichment of purine and pyrimidine metabolism, as well as the pentose-phosphate pathway, which is tightly connected to glycolysis (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). In line with these findings, a substrate oxidation test in BEC-organoids revealed a preference for glucose, as reflected by the decrease in maximal respiration, when UK5099, a mitochondrial pyruvate carrier inhibitor, was used (<xref ref-type="fig" rid="fig4">Figure 4A–B</xref>), while no changes were observed with inhibitors of glutamine (BPTES) and FA (Etomoxir) metabolism (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B–C</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>E2Fs promote glycolysis in biliary epithelial cell (BEC)-organoids.</title><p>(<bold>A–B</bold>) Seahorse Substrate Oxidation Assay using UK5099, a mitochondrial pyruvate carrier inhibitor (<bold>A</bold>), and assessment of the glucose dependency (<bold>B</bold>) in CD-derived BEC-organoids. n=7 for control (Ctrl), n=8 for UK5099. (<bold>C</bold>) Scheme depicting the treatment of chow diet (CD)/high-fat diet (HFD)-derived BEC-organoids with fatty acid (FA) mix. (<bold>D–E</bold>) Proton efflux rate (PER) (<bold>D</bold>), and basal and compensatory (Compens.) glycolysis (<bold>E</bold>) were measured using Seahorse XF Glycolytic Rate Assay. Relative to panel C. n=14. (<bold>F</bold>) Scheme depicting the treatment of CD-derived BEC-organoids with E2F inhibitor, HLM006474. (<bold>G</bold>) RT-qPCR of selected cell cycle and glycolytic genes, relative to panel F. n=4. (<bold>H–I</bold>) PER during the Seahorse XF Glycolytic Rate Assay (<bold>H</bold>), and basal and compensatory (Compens.) glycolysis (<bold>I</bold>), relative to panel F. n=10 for control (Ctrl), n=11 for HLM006474. (<bold>J–K</bold>) PER during the Seahorse XF Glycolytic Rate Assay (<bold>J</bold>), and basal and compensatory glycolysis (<bold>K</bold>), relative to panel C and treatment with HLM006474. n=12 for CD-FA and HFD-FA, n=11 for HLM006474. Data are shown as mean ± SEM. Absence of stars or ns, not significant (p&gt;0.05); *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001; ****p&lt;0.0001; unpaired, two-tailed Student’s t-test (<bold>G</bold>), and two-way ANOVA with Sidak’s test (<bold>B, E, I, K</bold>) were used.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81926-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>E2F activation correlates with increased glycolysis.</title><p>(<bold>A</bold>) Over-representation analysis results. Top 22 enriched KEGG and EHMN pathways during the process of organoid formation from single biliary epithelial cells (BECs) (Organoids vs. T0) (GSE123133). q-value: false discovery rate adjusted p-values, counts: number of found genes within a given gene set. (<bold>B–C</bold>) Seahorse Substrate Oxidation Assay using BPTES, n=8 (<bold>B</bold>), or Etomoxir (<bold>C</bold>) in CD-derived BEC-organoids. n=7 for control (Ctrl) and n=8 for inhibitor conditions (<bold>D–E</bold>) Scheme depicting Seahorse Glycolytic Rate Assay (<bold>D</bold>), and Mito Stress Test (<bold>E). (F–G</bold>) Oxygen consumption rate (OCR) (<bold>F</bold>), and basal and maximal respiration (<bold>G</bold>) were measured using Seahorse XF Mito Stress Test. Relative to <xref ref-type="fig" rid="fig4">Figure 4C</xref>. n=14. Data are shown as mean ± SEM. Absence of stars or ns, non-significant (p-value &gt;0.05); ****p&lt;0.0001; two-way ANOVA with Sidak’s test (<bold>B, C, G</bold>) was used.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81926-fig4-figsupp1-v2.tif"/></fig></fig-group><p>To investigate the metabolic changes in BEC-organoids upon HFD, we treated CD/HFD BEC-organoids with FA mix to mimic steatotic conditions in vitro (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). We hypothesized that the presence of glucose and FA in culture media would reveal a metabolic shift of BEC-organoids. Consistent with our hypothesis, HFD-FA BEC-organoids demonstrated increased compensatory glycolytic rates (<xref ref-type="fig" rid="fig4">Figure 4D–E</xref> and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D</xref>). Of note, there was a reduction in oxidative phosphorylation in HFD-FA BEC-organoids, as evidenced by the decrease in maximal respiration (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1E–G</xref>), which might reflect their preference for the glycolytic pathway to generate biomass.</p><p>Besides their prominent role in cell cycle progression, E2Fs coordinate several aspects of cellular metabolism (<xref ref-type="bibr" rid="bib15">Denechaud et al., 2017</xref>; <xref ref-type="bibr" rid="bib41">Nicolay and Dyson, 2013</xref>), and promote glycolysis in different contexts (<xref ref-type="bibr" rid="bib7">Blanchet et al., 2011</xref>; <xref ref-type="bibr" rid="bib14">Denechaud et al., 2016</xref>; <xref ref-type="bibr" rid="bib26">Huber et al., 2021</xref>). These findings prompted us to postulate that E2F might control glycolysis and, thus, the glucose preference observed in BEC-organoids. To investigate this hypothesis, we treated BEC organoids with an E2F inhibitor, HLM006474 (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). As expected, HLM006474 treatment reduced the transcriptional levels of several genes involved in cell cycle progression and glycolytic metabolism (<xref ref-type="fig" rid="fig4">Figure 4G</xref>) and decreased the glycolytic flux, as evidenced by the blunted proton efflux rate (PER) (<xref ref-type="fig" rid="fig4">Figure 4H–I</xref>). Moreover, E2F inhibition was able to reverse the metabolic phenotype only in HFD-FA BEC-organoids (<xref ref-type="fig" rid="fig4">Figure 4J–K</xref>).</p><p>In conclusion, these results demonstrate that HFD-induced E2F activation controls the conversion of BECs from quiescent to active progenitors by promoting the expression of cell cycle genes while simultaneously driving a shift toward glycolysis.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Through DR activation, BECs represent an essential reservoir of progenitors that are crucial for coordinating hepatic epithelial regeneration in the context of chronic liver diseases (<xref ref-type="bibr" rid="bib12">Choi et al., 2014</xref>; <xref ref-type="bibr" rid="bib16">Deng et al., 2018</xref>; <xref ref-type="bibr" rid="bib21">Español-Suñer et al., 2012</xref>; <xref ref-type="bibr" rid="bib27">Huch et al., 2013</xref>; <xref ref-type="bibr" rid="bib33">Lu et al., 2015</xref>; <xref ref-type="bibr" rid="bib46">Raven et al., 2017</xref>; <xref ref-type="bibr" rid="bib48">Rodrigo-Torres et al., 2014</xref>; <xref ref-type="bibr" rid="bib49">Russell et al., 2019</xref>). BEC functions are tightly controlled by YAP metabolic pathways (<xref ref-type="bibr" rid="bib37">Meyer et al., 2020</xref>; <xref ref-type="bibr" rid="bib44">Pepe-Mooney et al., 2019</xref>; <xref ref-type="bibr" rid="bib45">Planas-Paz et al., 2019</xref>), and recent studies from different tissues have provided evidence that specific metabolic states play instructive roles in controlling cell fate and tissue regeneration (<xref ref-type="bibr" rid="bib6">Beyaz et al., 2016</xref>; <xref ref-type="bibr" rid="bib11">Capolupo et al., 2022</xref>; <xref ref-type="bibr" rid="bib38">Miao et al., 2020</xref>; <xref ref-type="bibr" rid="bib65">Zhang et al., 2016</xref>). Aberrant lipid accumulation is a hallmark of early NAFLD, and imbalances in lipid metabolism are known to affect hepatocyte homeostasis, including induction of lipo-toxicity and cell death (<xref ref-type="bibr" rid="bib60">Wang et al., 2016b</xref>; <xref ref-type="bibr" rid="bib51">Sano et al., 2021</xref>; <xref ref-type="bibr" rid="bib13">De Gottardi et al., 2007</xref>; <xref ref-type="bibr" rid="bib62">Wobser et al., 2009</xref>; <xref ref-type="bibr" rid="bib29">Ipsen et al., 2018</xref>). However, the role of lipid dysregulation in BECs and whether it has an impact on BEC activation remains unexplored in the setting of NAFLD.</p><p>Here, using HFD- fed mouse models, we studied BEC metabolism in steatosis, the first stage of NAFLD, and demonstrated lipid accumulation in BECs during chronic HFD in vivo and their resistance to lipid-induced toxicity. By using BEC-organoids, we observed that FAs directly target BECs, without any involvement of hepatocytes and that BECs functionally respond to lipid overload. Importantly, BEC-organoids derived from CD- and HFD-fed mouse livers were shown to shift their cellular metabolism toward more glycolysis in the presence of lipids. Furthermore, we found that the HFD-induced metabolic shift was sufficient to reprogram BEC identity in vivo, allowing their exit from a quiescent state and the simultaneous acquisition of progenitor functions, such as proliferation and organoid-initiating capacity. These results highlight the metabolic plasticity of BECs and shed light on an unpredicted mechanism of BEC activation in HFD-induced hepatic steatosis. Importantly, we observed that lipid overload is sufficient to induce BEC activation in steatotic livers and that this process precedes parenchymal damage. While the functional contribution of lipid-activated BECs in liver regeneration during the late stages of NAFLD will require further studies, our data clearly point out the role of BECs as sensors and possibly effectors of early liver diseases such as steatosis.</p><p>To fully understand the underlying basis of the observed phenotype, we characterized the transcriptome of primary BECs derived from steatotic livers of HFD-fed mice and demonstrated that long-term feeding of a lipid-enriched diet strongly promotes BEC proliferation, suggesting a strong link between metabolic adaptation and progenitor function. By combining our transcriptomic analysis with data mining of publicly available DR datasets (<xref ref-type="bibr" rid="bib2">Aloia et al., 2019</xref>; <xref ref-type="bibr" rid="bib44">Pepe-Mooney et al., 2019</xref>), we identified the E2F transcription factors as master regulators of BEC activation in the context of NAFLD. Moreover, the expression of <italic>Pdk4,</italic> an E2F1 target (<xref ref-type="bibr" rid="bib25">Hsieh et al., 2008</xref>; <xref ref-type="bibr" rid="bib59">Wang et al., 2016a</xref>), was upregulated in FA-treated BEC-organoids and upon HFD. PDK4 limits the utilization of pyruvate for oxidative metabolism while enhancing glycolysis, which reinforces our data demonstrating that E2Fs rewire BEC metabolism toward glycolysis to fuel progenitor proliferation. These observations feature E2Fs as the molecular rheostat integrating the metabolic cell state with the cell cycle machinery to coordinate BEC activation. However, how E2Fs are regulated upon HFD and whether they are interconnected with the already known YAP, mTORC1, and TET1 pathways remain unknown and will require further investigation.</p><p>While our data are derived from obese mice, a recent report showed increased numbers of cholangiocytes in steatotic human livers (<xref ref-type="bibr" rid="bib24">Hallett et al., 2022</xref>), and E2F1 has been found to be upregulated in the livers of obese patients (<xref ref-type="bibr" rid="bib14">Denechaud et al., 2016</xref>). Moreover, human subjects with elevated visceral fat demonstrated increased glucose metabolism (<xref ref-type="bibr" rid="bib8">Broadfield et al., 2021</xref>). These observations, while correlative, set the ground for future research in understanding the role and the therapeutic potential of lipid metabolism and E2Fs in controlling BEC activation and, thus, hepatic regeneration in humans.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Mouse studies and ethical approval</title><p>All the animal experiments were authorized by the Veterinary Office of the Canton of Vaud, Switzerland, under license authorizations VD3721 and VD2627.b. C57BL/6JRj (in the text referred to as C57BL/6 J) mice were obtained from Janvier Labs and <italic>E2f1<sup>+/+</sup></italic> and <italic>E2f1<sup>–/–</sup></italic> (B6;129S4-E2f1tm1 Meg/J) mice were purchased from The Jackson Laboratory. 8-week-old C57BL/6 J male mice were fed with Chow Diet (CD - SAFE Diets, SAFE 150) or High Fat Diet (HFD - Research Diets Inc, D12492i) for 15 weeks. 7-week-old <italic>E2f1<sup>+/+</sup></italic> and <italic>E2f1<sup>–/–</sup></italic> male mice were fed with Chow Diet (CD – Kliba Nafag 3336) or High Fat Diet (HFD - Envigo, TD93075) for 29 weeks. The well-being of the animals was monitored daily, and body weight was monitored once per week until the end of the experiment. All mice had unrestricted access to water and food, and liver tissues were harvested at the end of the experiment.</p></sec><sec id="s4-2"><title>Data reporting</title><p>Mice were randomized into different groups according to their genotype. A previous HFD experiment was used to calculate the sample size for C57BL/6 J mouse experiments. Mice showing any sign of severity, predefined by the Veterinary Office of the Canton of Vaud, Switzerland, were sacrificed and excluded from the data analyses. In vitro experiments were repeated with at least three biological replicates (BEC-organoids from different mice) or were repeated at least twice by pooling four mice per condition (for Seahorse analysis).</p></sec><sec id="s4-3"><title>Proliferation assay</title><p>Cell proliferation was assessed by EdU assay (Click-iT EdU Alexa Fluor 647, ThermoFisher, C10340) following the manufacturer’s instructions. For in vivo studies, EdU was resuspended in phosphate-buffered saline (PBS- ThermoFisher, 10010002), and 200 μl of the solution was injected intraperitoneally (50 μg per g of mouse weight) 16 hr before the sacrifice.</p></sec><sec id="s4-4"><title>EPCAM<sup>+</sup> BEC isolation, FACS, and flow cytometry analysis</title><p>23-week-old CD/HFD-fed C57BL/6 J male mice were used for this experiment and sacrificed in the fed state. To isolate the BECs, mouse livers were harvested and digested enzymatically, as previously reported (<xref ref-type="bibr" rid="bib9">Broutier et al., 2016</xref>). Briefly, livers were minced and incubated at 37 °C for up to 2 hr in a digestion solution (1% fetal bovine serum [FBS; Merck/Sigma, F7524] in DMEM/Glutamax [ThermoFisher, 31966–021] supplemented with HEPES [ThermoFisher, 15630–056] and Penicillin/Streptomycin [ThermoFisher, 15140–122] containing 0.0125% [mg/ml] collagenase [Merck/Sigma, C9407], 0.0125% [mg/ml] dispase II [ThermoFisher, 17105–041] and 0.1 mg/ml of DNAase [Merck/Sigma, DN25]). Digested livers were then dissociated into single cells with TrypLE [GIBCO, 12605028] and washed with washing buffer (1% FBS [Merck/Sigma, F7524] in Advanced DMEM/F-12 [GIBCO, 12634010] supplemented with Glutamax [ThermoFisher, 35050061], HEPES [ThermoFisher, 15630–056] and Penicillin/Streptomycin [ThermoFisher, 15140–122]).</p><p>For FACS analysis, single cells were filtered with a 40 µm cell strainer (Falcon, 352340) and incubated with fluorophore-conjugated antibodies CD45–PE/Cy7 (BD Biosciences, 552848), CD11b–PE/Cy7 (BD Biosciences, 552850), CD31–PE/Cy7 (Abcam, ab46733), CD31-PE/Cy7 (BD Biosciences, 561410) and EPCAM–APC (eBioscience, 17-5791-82) for 30 min on ice. BECs were sorted using FACSAria Fusion (BD Biosciences) as previously described (<xref ref-type="bibr" rid="bib2">Aloia et al., 2019</xref>). Briefly, individual cells were sequentially gated based on cell size (forward scatter (FSC) versus side scatter (SSC)) and singlets. BECs were then selected based on EPCAM positivity after excluding leukocytes (CD45<sup>+</sup>), myeloid cells (CD11b<sup>+</sup>), and endothelial cells (CD31<sup>+</sup>), yielding a population of single CD45<sup>-</sup>/CD11b<sup>-</sup>/ CD31<sup>-</sup>/EPCAM<sup>+</sup> cells.</p><p>For flow cytometry analysis, livers were dissociated as described above, and single cells were stained for 20 min with BODIPY 558/568 (Invitrogen, D38D35) on ice, followed by incubation with fluorophore-conjugated antibodies CD45–PE/Cy7 (BD Biosciences, 552848), CD11b–PE/Cy7 (BD Biosciences, 552850), CD31–PE/Cy7 (BD Biosciences, 561410), EPCAM–VioBlue (Miltenyi Biotec, 130-123-871), and EdU Alexa Fluor 488 (ThermoFisher, C10425) for 30 min on ice. After washing with 1% BSA in PBS, the Click-IT EdU reaction (ThermoFisher, C10425) was performed according to the manufacturer’s instructions. Finally, BEC suspension was resuspended in 1% BSA in PBS, and analyzed using BD LSRFortessa (BD Biosciences). All flow cytometry data were analyzed with FlowJo v10.8 software (BD Life Sciences).</p></sec><sec id="s4-5"><title>Silencing of E2F1 in EPCAM<sup>+</sup> BECs and organoid formation</title><p>To silence E2F1, 2 × 10<sup>4</sup> EPCAM<sup>+</sup> BECs isolated from the livers of HFD-fed mice were transfected with a pool of four ON-TARGETplus siRNAs for <italic>E2f1</italic> (Horizon, L-044993-00-0005) or with scrambled siRNAs (Horizon, D-001810-10-05), using TransIT-X2 (Mirus, MIR6000) according to the manufacturer’s instructions. Briefly, the cells and the TransIT-X2 mix were centrifuged at 600 g for 45  min at 32  °C and then incubated for 4  hr at 37  °C. The cell suspension was harvested and seeded in Matrigel in the isolation medium. Growth of BEC-organoids was followed with a luminescent MT Cell Viability Assay (Promega, G9711).</p></sec><sec id="s4-6"><title>RNA preparation from EPCAM<sup>+</sup> BECs and bulk RNA-seq data analysis</title><p>RNA was isolated from sorted BECs using the RNeasy micro kit (QIAGEN, 74104), and the amount and quality of RNA were measured with the Agilent Tapestation 4200 (Agilent Technologies, 5067–1511). As a result, RNA-seq of five CD and seven HFD samples was performed by BGI with the BGISEQ-500 platform. FastQC was used to verify the quality of the reads (<xref ref-type="bibr" rid="bib3">Andrews, 2010</xref>). No low-quality reads were present, and no trimming was needed. Alignment was performed against the mouse genome (GRCm38) following the STAR (version 2.6.0 a) manual guidelines (<xref ref-type="bibr" rid="bib18">Dobin et al., 2013</xref>). The obtained STAR gene counts for each alignment were analyzed for differentially expressed genes using the R package DESeq2 (version 1.34.0) (<xref ref-type="bibr" rid="bib32">Love et al., 2014</xref>). A threshold of 1 log2 fold change and adjusted p-value smaller than 0.05 were considered when identifying the differentially expressed genes. A principal component analysis (PCA) (<xref ref-type="bibr" rid="bib30">Lê et al., 2008</xref>) was used to explore the variability between the different samples.</p></sec><sec id="s4-7"><title>Gene set enrichment analysis (GSEA)</title><p>We used the clusterProfiler R package (<xref ref-type="bibr" rid="bib64">Yu et al., 2012</xref>) to conduct GSEA analysis on various gene sets. Gene sets were retrieved from <ext-link ext-link-type="uri" xlink:href="http://ge-lab.org/gskb/">http://ge-lab.org/gskb/</ext-link> for <italic>M. musculus</italic>. We ordered the differentially expressed gene list by log2 (Fold-changes) for the analysis with default parameters.</p></sec><sec id="s4-8"><title>Over-representation enrichment analysis</title><p>All significantly changing genes (adjusted p-value &lt;0.05 and an absolute fold change &gt;1) were split into 2 groups based on the direction of the fold change (genes significantly up- &amp; down-regulated). An over-representation analysis using the clusterProfiler R package was performed on each of the two groups to identify biologically overrepresented terms.</p></sec><sec id="s4-9"><title>Figure generation with R</title><p>The R packages ggplot2 (<xref ref-type="bibr" rid="bib61">Wickham, 2016</xref>) retrieved from <ext-link ext-link-type="uri" xlink:href="https://ggplot2.tidyverse.org">https://ggplot2.tidyverse.org</ext-link> and ggpubr were used to generate figures.</p></sec><sec id="s4-10"><title>Culture of mouse liver BEC-organoids from single bile duct cells of digested livers</title><p>BEC-organoids were established from bile ducts of C57BL/6 J male mice as previously described (<xref ref-type="bibr" rid="bib9">Broutier et al., 2016</xref>; <xref ref-type="bibr" rid="bib56">Sorrentino et al., 2020</xref>). Thus, the liver was digested as detailed above (EPCAM<sup>+</sup> BEC isolation), and bile ducts were isolated and were pelleted by centrifugation at 200 rpm for 5 min at 4 °C and washed with PBS twice. The digested liver solution, including single bile duct cells, was then dissociated into single cells with TrypLE (GIBCO, 12605028). Isolated cells were resuspended in Matrigel (Corning, 356231) and cast in 10 µl droplets in 48-well plates. When gels were formed, 250 µl of isolation medium (IM- Advanced DMEM/F-12- Gibco,12634010) supplemented with Glutamax (ThermoFisher, 35050061), HEPES (ThermoFisher, 15630–056), Penicillin/Streptomycin (ThermoFisher, 15140–122), 1 X B27 (Gibco, 17504044), 1 mM <italic>N</italic>-acetylcysteine (Sigma-Aldrich, A9165), 10  nM gastrin (Sigma-Aldrich, G9145), 50  ng/ml EGF (Peprotech, AF-100–15), 1  µg/ml Rspo1 (produced in-house), 100  ng/ml FGF10 (Peprotech, 100–26), 10  mM nicotinamide (Sigma-Aldrich, N0636), 50  ng/ml HGF (Peprotech, 100–39), Noggin (100  ng/ml produced in-house), 1 µg/ml Wnt3a (Peprotech, 315–20), and 10 μM Y-27632 (Sigma, Y0503) was added to each well. Plasmids for Rspo1 and Noggin production were a kind gift from Joerg Huelsken. After the first 4 days, IM was replaced with the expansion medium (EM), which was the IM without Noggin, Wnt3a, and Y-27632. For passaging, organoids were removed from Matrigel for a maximum of one week after seeding and dissociated into single cells using TrypLE Express (Gibco, 12604013). Single cells were then transferred to fresh Matrigel. Passaging was performed in a 1:3 split ratio.</p><p>For the FA treatment of BEC-organoids, palmitic acid (Sigma, P0500) and oleic acid (Sigma, O1008) were dissolved in 100% ethanol into 500 and 800 μM stock solutions, respectively, and kept at –20  °C. For each experiment, palmitic acid and oleic acid were conjugated to 1% fatty acid-free bovine serum albumin (BSA) (Sigma, A7030) in EM through 1:2000 dilution each (<xref ref-type="bibr" rid="bib35">Malhi et al., 2006</xref>). The concentration of vehicle, ethanol, was 0.1% ethanol in final incubations, and 1% fatty acid-free BSA in EM was used as the control for FA treatment.</p></sec><sec id="s4-11"><title>Liver immunohistochemistry (IHC) and immunofluorescence (IF)</title><p>For paraffin histology, livers were washed in PBS (Gibco, 10010023), diced with a razor blade, and fixed overnight in 10% formalin (ThermoFisher, 9990244) while shaking at 4 °C. The next day fixed livers were washed twice with PBS, dehydrated in ascending ethanol steps, followed by xylene, and embedded in paraffin blocks. 4 μm thick sections were cut from paraffin blocks, dewaxed, rehydrated, and quenched with 3% H<sub>2</sub>O<sub>2</sub> for 10 min to block the endogenous peroxidase activity (for IHC). Antigen retrieval was performed by incubating the sections in 10 mM citrate buffer (pH 6.0) for 20  min at 95  °C. After the sections were cooled to room temperature, they were washed and blocked with blocking buffer (1% BSA (Sigma, A7906) and 0.5% Triton X-100 (Sigma, X100) in PBS) for 1  hr at room temperature. The primary antibodies anti-Ki67 (ThermoFisher, MA5-14520), anti-PANCK (Novusbio, NBP600-579), anti-OPN (R&amp;D Systems, AF808), anti-Cleaved caspase-3 (Cell Signaling, 9661) were diluted in a 1:100 dilution of the blocking buffer and incubated overnight at 4  °C. For IHC, ImmpRESS HRP conjugated secondary (VectorLabs MP-74-01-15 and MP-74-02-15) were incubated for 30 min, and detection was performed by using a 3.3’-diaminobenzidine (DAB) reaction. Sections were counterstained with Harris and mounted. For IF, sections were washed and incubated for 1 hr with Alexa Fluor conjugated secondary antibodies (1:1000 in blocking solution; Invitrogen). Following extensive washing, sections were counterstained with DAPI (ThermoFisher, 62248) and mounted in ProLong Gold Antifade Mountant (Thermo Fischer, P36930).</p><p>For IF of liver cryosections, the livers were frozen in O.C.T. compound (VWR chemicals) on dry ice filled with isopentane. 10 μm liver sections were cut from O.C.T embedded samples, hydrated, and washed twice in PBS. The sections were blocked in a blocking buffer for 1 hr at room temperature and incubated with BODIPY for 20 min. After fixation with 4% paraformaldehyde (PFA) solution (Sigma, 1004960700) for 15 min, sections were washed with PBS. Then, sections were permeabilized using 5% BSA in TBS-T and stained with primary antibody anti-PANCK diluted in blocking buffer for 16  hr at 4  °C. The next day, the sections were washed three times with PBS, and the appropriate Alexa Fluor secondary antibodies were diluted in blocking buffer (1:1000) and incubated with the sections for 1  hr at room temperature. The sections were washed in PBS and incubated with DAPI diluted 1:1000 in PBS for 1  hr at room temperature. Finally, the sections were mounted in ProLong Gold Antifade Mountant.</p><p>Stained sections were imaged by a virtual slide microscope (VS120, Olympus) and a confocal microscope (SP8, Leica). The image analysis was performed using QuPath (<xref ref-type="bibr" rid="bib5">Bankhead et al., 2017</xref>) and Fiji software.</p></sec><sec id="s4-12"><title>BEC-organoid whole-mount immunofluorescence</title><p>BEC-organoids were incubated with BODIPY 558/568 for 20 min and then washed with PBS and extracted from Matrigel using Cell Recovery Solution (Corning, 354253). After fixing with 4% PFA in PBS (30 min, on ice), they were pelleted by gravity to remove the PFA and were washed with PBS and ultra-pure water. BEC-organoids were then spread on glass slides and allowed to attach by drying. The attached BEC-organoids were rehydrated with PBS and permeabilized with 0.5% Triton X-100 in PBS (1 hr, room temperature) and blocked for 1 hr in a blocking buffer. After washing with PBS, samples were incubated for 1 hr at room temperature with Alexa Fluor Phalloidin 488 (Invitrogen, A12379). Following extensive washing, samples were counterstained with DAPI and were imaged by a confocal microscope (LSM 710, Zeiss). Signal intensity was adjusted on each channel using Fiji software (<xref ref-type="bibr" rid="bib53">Schindelin et al., 2012</xref>).</p></sec><sec id="s4-13"><title>Quantitative real-time qPCR for mRNA quantification</title><p>BEC-organoids were extracted from Matrigel using Cell Recovery Solution (Corning, 354253). RNA was extracted from organoid pellets using the RNAqueous total RNA isolation kit (Invitrogen, AM1931) and the RNeasy Micro Kit (Qiagen, 74004) following the manufacturer’s instructions. RNA was transcribed to complementary DNA using QuantiTect Reverse Transcription Kit (Qiagen, 205314) following the manufacturer’s instructions. PCR reactions were run on the LightCycler 480 System (Roche) using SYBR Green (Roche, 4887352001) chemistry. Real-time quantitative polymerase chain reaction (RT-qPCR) results were presented relative to the mean of <italic>36b4</italic> (comparative ΔCt method). Primers for RT-qPCR are listed in <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>.</p></sec><sec id="s4-14"><title>E2F inhibition</title><p>For the E2F inhibition experiment, single BECs were grown for 7 days and allowed to form organoids. For the Seahorse experiment, BEC-organoids were treated with E2F inhibitor, HLM006474 (10 μM, Merck, 324461), overnight before the metabolic assay. For RT-qPCR analysis, BEC-organoids were treated with HLM006474 chronically for 4 days.</p></sec><sec id="s4-15"><title>Bioenergetics with Seahorse extracellular flux analyzer</title><p>The oxygen consumption rate (OCR), extracellular acidification rate (ECAR), and proton-efflux rate (PER) of the BEC-organoids were analyzed by an XFe96 extracellular flux analyzer (Agilent) following the manufacturer’s instructions according to assay type.</p><p>For Mito Stress Test on CD/HFD-derived BEC-organoids, the organoids were grown with FA mix for 7 days. On day 7, 10 μM HLM006474 or DMSO as vehicle were added overnight. The next morning, BEC-organoids were dissociated, and 20,000 cells were seeded with Seahorse Assay Medium in XFe96 Cell Culture Microplates (Agilent, 101085–004), which were previously coated with 10% Matrigel in Advanced DMEM/F-12. Seahorse Assay Medium was unbuffered, serum-free pH 7.4 DMEM supplemented with 10 mM glucose (Agilent, 103577–100), 10 mM pyruvate (Gibco, 11360070), and 2 mM glutamine (Agilent, 103579–100), and 10 μM HLM006474 or DMSO (vehicle) were added when indicated. After 2 hr incubation for cell attachment, plates were transferred to a non-CO<sup>2</sup> incubator at 37 °C for 45 min. Mitochondrial OCR was measured in a time course before and after the injection of 1.5 μM Oligomycin (Millipore, 495455), 2.5 μM FCCP (Sigma, C2920), and 1 μM Rotenone (Sigma, R8875)/Antimycin A (Sigma, A8674).</p><p>For Glycolytic Rate Assay, CD BEC-organoids were grown without FA mix, and CD/HFD- derived BEC-organoids were grown with FA mix for 7 days. The Seahorse assay preparations, including the E2F inhibitor were the same as mentioned above. GlycoPER was measured in a time course before and after the injection of 1 μM Rotenone/Antimycin A and 50 mM 2-DG (Sigma, D8375).</p><p>For the Substrate Oxidation Assay, CD BEC-organoids were grown without FA mix for 7 days. On day 8, they were dissociated and prepared for Seahorse assay without E2F inhibitor. Mitochondrial OCR was measured in a time course before and after the injection of Oligomycin (1.5 μM), FCCP (2.5 μM), and Rotenone/Antimycin A (1 μM) with or without UK5099 (Sigma, PZ0160), Etomoxir (Sigma, E1905) and BPTES (Sigma, SML0601), inhibitors of glucose oxidation, fatty acid oxidation and glutamine oxidation, respectively, in separate experiments.</p><p>All Seahorse experiments were normalized by cell number through injection of 10 μM of Hoechst (ThermoFisher, 62249) in the last Seahorse injection. Hoechst signal (361/486 nm) was quantified by SpectraMax iD3 microplate reader (Molecular Devices).</p></sec><sec id="s4-16"><title>BEC-organoid growth assay</title><p>BEC-organoid formation efficiency was quantified by counting the total number of cystic/single layer (lumen-containing) CD/HFD-derived BEC-organoids 6 days after seeding and normalizing it to the total number of cells seeded initially (15,000 cells). Organoids were imaged by DM IL LED inverted microscope (Leica), selected as regions of interest (ROI) using widefield 4 x magnification, and counted manually.</p></sec><sec id="s4-17"><title>BEC-organoid functional analysis</title><p>Grown BEC-organoids were treated with the FA mix for 4 days, and triglyceride levels were measured with a Triglyceride kit (Abcam, ab65336) following the manufacturer’s instructions. Cell-titer Glo (Promega, G7570) was used to investigate cell viability. For functional assays involving single BECs, grown organoids were dissociated into single cells. 10,000 BECs were seeded, and organoid formation was allowed for 7 days. Cell viability, apoptosis, and cell death were investigated using Cell-titer Glo, Caspase 3/7 activity (Promega, G8091), and Nucgreen Dead 488 staining (Invitrogen, R37109), respectively, according to the protocol of manufacturers. For cell death staining, organoids were imaged using ECLIPSE Ts2 inverted microscope (Nikon).</p></sec><sec id="s4-18"><title>Quantification and statistical analysis</title><p>Data were presented as mean ± standard error of the mean (mean ± SEM). <italic>n</italic> refers to biological replicates and is represented by the number of dots in the plot or stated in the figure legends. For the Seahorse experiments, <italic>n</italic> refers to technical replicates pooled from 4 biological replicates and is represented by the number of dots in the plot or stated in the figure legends. The statistical analysis of the data from bench experiments was performed using Prism (Prism 9, GraphPad). The differences with p&lt;0.05 were considered statistically significant. No samples (except outliers) or animals were excluded from the analysis. Data are expected to have a normal distribution.</p><p>For two groups comparison, data significance was analyzed using a two-tailed, unpaired Student’s t-test. In case of comparisons between more than two groups, one- or two-way ANOVA was used. Dunnet’s, Tukey’s, or Sidak’s tests were used to correct for multiple comparisons. Statistical details of each experiment can be found in the respective figure legends.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Data curation, Software, Formal analysis, Investigation, Visualization, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Supervision, Visualization, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Investigation, Visualization, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Resources, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Resources, Writing – review and editing</p></fn><fn fn-type="con" id="con7"><p>Resources, Writing – review and editing</p></fn><fn fn-type="con" id="con8"><p>Resources, Writing – review and editing</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Supervision, Writing – review and editing</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Resources, Supervision, Funding acquisition, Investigation, Project administration, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All the animal experiments were authorized by the Veterinary Office of the Canton of Vaud, Switzerland, under license authorizations VD3721 and VD2627.b.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Differential expression analysis results of EPCAM<sup>+</sup> BECs upon HFD.</title><p>Related to <xref ref-type="fig" rid="fig2">Figure 2</xref>.</p></caption><media xlink:href="elife-81926-supp1-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Over-representation analysis of upregulated and downregulated genes in HFD, DDC, and BEC-organoid formation datasets.</title><p>Related to <xref ref-type="fig" rid="fig3">Figure 3</xref>.</p></caption><media xlink:href="elife-81926-supp2-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>Primers used for qPCR analysis.</title></caption><media xlink:href="elife-81926-supp3-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-81926-mdarchecklist1-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>Computational analysis was performed using established packages mentioned in the Materials and methods, and no new code was generated. RNA-Seq data have been deposited in GEO under accession code GSE217739. Two publicly available RNA-Seq datasets of mouse BECs with accession numbers GSE123133 (<xref ref-type="bibr" rid="bib2">Aloia et al., 2019</xref>) and GSE125688 (<xref ref-type="bibr" rid="bib44">Pepe-Mooney et al., 2019</xref>) were downloaded from the GEO and used for GSEA and over-representation enrichment analysis as mentioned previously. Source code is available at <ext-link ext-link-type="uri" xlink:href="https://github.com/auwerxlab/Yildiz_eLife_2023">https://github.com/auwerxlab/Yildiz_eLife_2023</ext-link> (copy archived at <xref ref-type="bibr" rid="bib1">Alam, 2023</xref>).</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Schoonjans</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>Hepatic lipid overload triggers biliary epithelial cell activation via E2Fs</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE217739">GSE217739</pub-id></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset2"><person-group person-group-type="author"><name><surname>Aloia</surname><given-names>L</given-names></name><name><surname>Vernaz</surname><given-names>G</given-names></name><name><surname>Huch</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>Transcriptonal and epigenetic changes of adult liver cells in vivo and in vitro</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE123133">GSE123133</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset3"><person-group person-group-type="author"><name><surname>Pepe-Mooney</surname><given-names>BJ</given-names></name><name><surname>Dill</surname><given-names>MT</given-names></name><name><surname>Alemany</surname><given-names>A</given-names></name><name><surname>Ordovas-Montanes</surname><given-names>J</given-names></name><name><surname>Matsushita</surname><given-names>Y</given-names></name><name><surname>Rao</surname><given-names>A</given-names></name><name><surname>Sen</surname><given-names>A</given-names></name><name><surname>Miyazaki</surname><given-names>M</given-names></name><name><surname>Anakk</surname><given-names>S</given-names></name><name><surname>Dawson</surname><given-names>P</given-names></name><name><surname>Ono</surname><given-names>N</given-names></name><name><surname>Shalek</surname><given-names>AK</given-names></name><name><surname>van Oudenaarden</surname><given-names>A</given-names></name><name><surname>Camargo</surname><given-names>FD</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>Single-Cell Analysis of the Liver Epithelium Reveals Dynamic Heterogeneity and an Essential Role for YAP in Homeostasis and Regeneration</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE125688">GSE125688</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Sabrina Bichet, Fabiana Fraga, and Jéromine Imbach for technical assistance, the EPFL-SV core facilities for support, and Yu Sun for critically reviewing the manuscript. This work was funded by the Ecole Polytechnique Fédérale de Lausanne (EPFL), the Kristian Gerhard Jebsen Foundation, the Swiss National Science Foundation (SNSF N° 310030_189178 to KS; SNSF N° 31003 A_179435 to JA), and AIRC Start-Up 2020 - ID.24322 to GS.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Alam</surname><given-names>GE</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>Yildiz_eLife_2023</data-title><version designator="swh:1:rev:5e7b6e97c501793a39adf9d899986375ba0d758e">swh:1:rev:5e7b6e97c501793a39adf9d899986375ba0d758e</version><source>Software Heritage</source><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:13f0b34e0d5b078e5dd3667d314f852b003047d4;origin=https://github.com/auwerxlab/Yildiz_eLife_2023;visit=swh:1:snp:3c2a61346447719f0ce157b518a54feee45b1230;anchor=swh:1:rev:5e7b6e97c501793a39adf9d899986375ba0d758e">https://archive.softwareheritage.org/swh:1:dir:13f0b34e0d5b078e5dd3667d314f852b003047d4;origin=https://github.com/auwerxlab/Yildiz_eLife_2023;visit=swh:1:snp:3c2a61346447719f0ce157b518a54feee45b1230;anchor=swh:1:rev:5e7b6e97c501793a39adf9d899986375ba0d758e</ext-link></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aloia</surname><given-names>L</given-names></name><name><surname>McKie</surname><given-names>MA</given-names></name><name><surname>Vernaz</surname><given-names>G</given-names></name><name><surname>Cordero-Espinoza</surname><given-names>L</given-names></name><name><surname>Aleksieva</surname><given-names>N</given-names></name><name><surname>van den Ameele</surname><given-names>J</given-names></name><name><surname>Antonica</surname><given-names>F</given-names></name><name><surname>Font-Cunill</surname><given-names>B</given-names></name><name><surname>Raven</surname><given-names>A</given-names></name><name><surname>Aiese Cigliano</surname><given-names>R</given-names></name><name><surname>Belenguer</surname><given-names>G</given-names></name><name><surname>Mort</surname><given-names>RL</given-names></name><name><surname>Brand</surname><given-names>AH</given-names></name><name><surname>Zernicka-Goetz</surname><given-names>M</given-names></name><name><surname>Forbes</surname><given-names>SJ</given-names></name><name><surname>Miska</surname><given-names>EA</given-names></name><name><surname>Huch</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Epigenetic remodelling licences adult cholangiocytes for organoid formation and liver regeneration</article-title><source>Nature Cell Biology</source><volume>21</volume><fpage>1321</fpage><lpage>1333</lpage><pub-id pub-id-type="doi">10.1038/s41556-019-0402-6</pub-id><pub-id pub-id-type="pmid">31685987</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Andrews</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2010">2010</year><source>FastQC: A Quality Control Tool for High Throughput Sequence Data</source><publisher-name>Babraham Bioinformatics</publisher-name></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Araya</surname><given-names>J</given-names></name><name><surname>Rodrigo</surname><given-names>R</given-names></name><name><surname>Videla</surname><given-names>LA</given-names></name><name><surname>Thielemann</surname><given-names>L</given-names></name><name><surname>Orellana</surname><given-names>M</given-names></name><name><surname>Pettinelli</surname><given-names>P</given-names></name><name><surname>Poniachik</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Increase in long-chain polyunsaturated fatty acid N - 6/N - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease</article-title><source>Clinical Science</source><volume>106</volume><fpage>635</fpage><lpage>643</lpage><pub-id pub-id-type="doi">10.1042/CS20030326</pub-id><pub-id pub-id-type="pmid">14720121</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bankhead</surname><given-names>P</given-names></name><name><surname>Loughrey</surname><given-names>MB</given-names></name><name><surname>Fernández</surname><given-names>JA</given-names></name><name><surname>Dombrowski</surname><given-names>Y</given-names></name><name><surname>McArt</surname><given-names>DG</given-names></name><name><surname>Dunne</surname><given-names>PD</given-names></name><name><surname>McQuaid</surname><given-names>S</given-names></name><name><surname>Gray</surname><given-names>RT</given-names></name><name><surname>Murray</surname><given-names>LJ</given-names></name><name><surname>Coleman</surname><given-names>HG</given-names></name><name><surname>James</surname><given-names>JA</given-names></name><name><surname>Salto-Tellez</surname><given-names>M</given-names></name><name><surname>Hamilton</surname><given-names>PW</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>QuPath: open source software for digital pathology image analysis</article-title><source>Scientific Reports</source><volume>7</volume><elocation-id>16878</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-017-17204-5</pub-id><pub-id pub-id-type="pmid">29203879</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beyaz</surname><given-names>S</given-names></name><name><surname>Mana</surname><given-names>MD</given-names></name><name><surname>Roper</surname><given-names>J</given-names></name><name><surname>Kedrin</surname><given-names>D</given-names></name><name><surname>Saadatpour</surname><given-names>A</given-names></name><name><surname>Hong</surname><given-names>SJ</given-names></name><name><surname>Bauer-Rowe</surname><given-names>KE</given-names></name><name><surname>Xifaras</surname><given-names>ME</given-names></name><name><surname>Akkad</surname><given-names>A</given-names></name><name><surname>Arias</surname><given-names>E</given-names></name><name><surname>Pinello</surname><given-names>L</given-names></name><name><surname>Katz</surname><given-names>Y</given-names></name><name><surname>Shinagare</surname><given-names>S</given-names></name><name><surname>Abu-Remaileh</surname><given-names>M</given-names></name><name><surname>Mihaylova</surname><given-names>MM</given-names></name><name><surname>Lamming</surname><given-names>DW</given-names></name><name><surname>Dogum</surname><given-names>R</given-names></name><name><surname>Guo</surname><given-names>G</given-names></name><name><surname>Bell</surname><given-names>GW</given-names></name><name><surname>Selig</surname><given-names>M</given-names></name><name><surname>Nielsen</surname><given-names>GP</given-names></name><name><surname>Gupta</surname><given-names>N</given-names></name><name><surname>Ferrone</surname><given-names>CR</given-names></name><name><surname>Deshpande</surname><given-names>V</given-names></name><name><surname>Yuan</surname><given-names>GC</given-names></name><name><surname>Orkin</surname><given-names>SH</given-names></name><name><surname>Sabatini</surname><given-names>DM</given-names></name><name><surname>Yilmaz</surname><given-names>ÖH</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>High-fat diet enhances stemness and tumorigenicity of intestinal progenitors</article-title><source>Nature</source><volume>531</volume><fpage>53</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1038/nature17173</pub-id><pub-id pub-id-type="pmid">26935695</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanchet</surname><given-names>E</given-names></name><name><surname>Annicotte</surname><given-names>JS</given-names></name><name><surname>Lagarrigue</surname><given-names>S</given-names></name><name><surname>Aguilar</surname><given-names>V</given-names></name><name><surname>Clapé</surname><given-names>C</given-names></name><name><surname>Chavey</surname><given-names>C</given-names></name><name><surname>Fritz</surname><given-names>V</given-names></name><name><surname>Casas</surname><given-names>F</given-names></name><name><surname>Apparailly</surname><given-names>F</given-names></name><name><surname>Auwerx</surname><given-names>J</given-names></name><name><surname>Fajas</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>E2F transcription factor-1 regulates oxidative metabolism</article-title><source>Nature Cell Biology</source><volume>13</volume><fpage>1146</fpage><lpage>1152</lpage><pub-id pub-id-type="doi">10.1038/ncb2309</pub-id><pub-id pub-id-type="pmid">21841792</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broadfield</surname><given-names>LA</given-names></name><name><surname>Duarte</surname><given-names>JAG</given-names></name><name><surname>Schmieder</surname><given-names>R</given-names></name><name><surname>Broekaert</surname><given-names>D</given-names></name><name><surname>Veys</surname><given-names>K</given-names></name><name><surname>Planque</surname><given-names>M</given-names></name><name><surname>Vriens</surname><given-names>K</given-names></name><name><surname>Karasawa</surname><given-names>Y</given-names></name><name><surname>Napolitano</surname><given-names>F</given-names></name><name><surname>Fujita</surname><given-names>S</given-names></name><name><surname>Fujii</surname><given-names>M</given-names></name><name><surname>Eto</surname><given-names>M</given-names></name><name><surname>Holvoet</surname><given-names>B</given-names></name><name><surname>Vangoitsenhoven</surname><given-names>R</given-names></name><name><surname>Fernandez-Garcia</surname><given-names>J</given-names></name><name><surname>Van Elsen</surname><given-names>J</given-names></name><name><surname>Dehairs</surname><given-names>J</given-names></name><name><surname>Zeng</surname><given-names>J</given-names></name><name><surname>Dooley</surname><given-names>J</given-names></name><name><surname>Rubio</surname><given-names>RA</given-names></name><name><surname>van Pelt</surname><given-names>J</given-names></name><name><surname>Grünewald</surname><given-names>TGP</given-names></name><name><surname>Liston</surname><given-names>A</given-names></name><name><surname>Mathieu</surname><given-names>C</given-names></name><name><surname>Deroose</surname><given-names>CM</given-names></name><name><surname>Swinnen</surname><given-names>JV</given-names></name><name><surname>Lambrechts</surname><given-names>D</given-names></name><name><surname>di Bernardo</surname><given-names>D</given-names></name><name><surname>Kuroda</surname><given-names>S</given-names></name><name><surname>De Bock</surname><given-names>K</given-names></name><name><surname>Fendt</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Fat induces glucose metabolism in nontransformed liver cells and promotes liver tumorigenesis</article-title><source>Cancer Research</source><volume>81</volume><fpage>1988</fpage><lpage>2001</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-20-1954</pub-id><pub-id pub-id-type="pmid">33687947</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broutier</surname><given-names>L</given-names></name><name><surname>Andersson-Rolf</surname><given-names>A</given-names></name><name><surname>Hindley</surname><given-names>CJ</given-names></name><name><surname>Boj</surname><given-names>SF</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name><name><surname>Koo</surname><given-names>BK</given-names></name><name><surname>Huch</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Culture and establishment of self-renewing human and mouse adult liver and pancreas 3D organoids and their genetic manipulation</article-title><source>Nature Protocols</source><volume>11</volume><fpage>1724</fpage><lpage>1743</lpage><pub-id pub-id-type="doi">10.1038/nprot.2016.097</pub-id><pub-id pub-id-type="pmid">27560176</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Byrne</surname><given-names>CD</given-names></name><name><surname>Targher</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>NAFLD: a multisystem disease</article-title><source>Journal of Hepatology</source><volume>62</volume><fpage>S47</fpage><lpage>S64</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2014.12.012</pub-id><pub-id pub-id-type="pmid">25920090</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capolupo</surname><given-names>L</given-names></name><name><surname>Khven</surname><given-names>I</given-names></name><name><surname>Lederer</surname><given-names>AR</given-names></name><name><surname>Mazzeo</surname><given-names>L</given-names></name><name><surname>Glousker</surname><given-names>G</given-names></name><name><surname>Ho</surname><given-names>S</given-names></name><name><surname>Russo</surname><given-names>F</given-names></name><name><surname>Montoya</surname><given-names>JP</given-names></name><name><surname>Bhandari</surname><given-names>DR</given-names></name><name><surname>Bowman</surname><given-names>AP</given-names></name><name><surname>Ellis</surname><given-names>SR</given-names></name><name><surname>Guiet</surname><given-names>R</given-names></name><name><surname>Burri</surname><given-names>O</given-names></name><name><surname>Detzner</surname><given-names>J</given-names></name><name><surname>Muthing</surname><given-names>J</given-names></name><name><surname>Homicsko</surname><given-names>K</given-names></name><name><surname>Kuonen</surname><given-names>F</given-names></name><name><surname>Gilliet</surname><given-names>M</given-names></name><name><surname>Spengler</surname><given-names>B</given-names></name><name><surname>Heeren</surname><given-names>RMA</given-names></name><name><surname>Dotto</surname><given-names>GP</given-names></name><name><surname>La Manno</surname><given-names>G</given-names></name><name><surname>D’Angelo</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Sphingolipids control dermal fibroblast heterogeneity</article-title><source>Science</source><volume>376</volume><elocation-id>eabh1623</elocation-id><pub-id pub-id-type="doi">10.1126/science.abh1623</pub-id><pub-id pub-id-type="pmid">35420948</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>TY</given-names></name><name><surname>Ninov</surname><given-names>N</given-names></name><name><surname>Stainier</surname><given-names>DYR</given-names></name><name><surname>Shin</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Extensive conversion of hepatic biliary epithelial cells to hepatocytes after near total loss of hepatocytes in zebrafish</article-title><source>Gastroenterology</source><volume>146</volume><fpage>776</fpage><lpage>788</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2013.10.019</pub-id><pub-id pub-id-type="pmid">24148620</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Gottardi</surname><given-names>A</given-names></name><name><surname>Vinciguerra</surname><given-names>M</given-names></name><name><surname>Sgroi</surname><given-names>A</given-names></name><name><surname>Moukil</surname><given-names>M</given-names></name><name><surname>Ravier-Dall’Antonia</surname><given-names>F</given-names></name><name><surname>Pazienza</surname><given-names>V</given-names></name><name><surname>Pugnale</surname><given-names>P</given-names></name><name><surname>Foti</surname><given-names>M</given-names></name><name><surname>Hadengue</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Microarray analyses and molecular profiling of steatosis induction in immortalized human hepatocytes</article-title><source>Laboratory Investigation; a Journal of Technical Methods and Pathology</source><volume>87</volume><fpage>792</fpage><lpage>806</lpage><pub-id pub-id-type="doi">10.1038/labinvest.3700590</pub-id><pub-id pub-id-type="pmid">17558421</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denechaud</surname><given-names>PD</given-names></name><name><surname>Lopez-Mejia</surname><given-names>IC</given-names></name><name><surname>Giralt</surname><given-names>A</given-names></name><name><surname>Lai</surname><given-names>Q</given-names></name><name><surname>Blanchet</surname><given-names>E</given-names></name><name><surname>Delacuisine</surname><given-names>B</given-names></name><name><surname>Nicolay</surname><given-names>BN</given-names></name><name><surname>Dyson</surname><given-names>NJ</given-names></name><name><surname>Bonner</surname><given-names>C</given-names></name><name><surname>Pattou</surname><given-names>F</given-names></name><name><surname>Annicotte</surname><given-names>JS</given-names></name><name><surname>Fajas</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>E2F1 mediates sustained lipogenesis and contributes to hepatic steatosis</article-title><source>The Journal of Clinical Investigation</source><volume>126</volume><fpage>137</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.1172/JCI81542</pub-id><pub-id pub-id-type="pmid">26619117</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denechaud</surname><given-names>PD</given-names></name><name><surname>Fajas</surname><given-names>L</given-names></name><name><surname>Giralt</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>E2F1, a novel regulator of metabolism</article-title><source>Frontiers in Endocrinology</source><volume>8</volume><elocation-id>311</elocation-id><pub-id pub-id-type="doi">10.3389/fendo.2017.00311</pub-id><pub-id pub-id-type="pmid">29176962</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Feng</surname><given-names>RX</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Yi</surname><given-names>GR</given-names></name><name><surname>Zhang</surname><given-names>XN</given-names></name><name><surname>Yin</surname><given-names>C</given-names></name><name><surname>Yu</surname><given-names>HY</given-names></name><name><surname>Zhang</surname><given-names>JP</given-names></name><name><surname>Lu</surname><given-names>B</given-names></name><name><surname>Hui</surname><given-names>L</given-names></name><name><surname>Xie</surname><given-names>WF</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Chronic liver injury induces conversion of biliary epithelial cells into hepatocytes</article-title><source>Cell Stem Cell</source><volume>23</volume><fpage>114</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2018.05.022</pub-id><pub-id pub-id-type="pmid">29937200</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dimova</surname><given-names>DK</given-names></name><name><surname>Dyson</surname><given-names>NJ</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The E2F transcriptional network: old acquaintances with new faces</article-title><source>Oncogene</source><volume>24</volume><fpage>2810</fpage><lpage>2826</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1208612</pub-id><pub-id pub-id-type="pmid">15838517</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobin</surname><given-names>A</given-names></name><name><surname>Davis</surname><given-names>CA</given-names></name><name><surname>Schlesinger</surname><given-names>F</given-names></name><name><surname>Drenkow</surname><given-names>J</given-names></name><name><surname>Zaleski</surname><given-names>C</given-names></name><name><surname>Jha</surname><given-names>S</given-names></name><name><surname>Batut</surname><given-names>P</given-names></name><name><surname>Chaisson</surname><given-names>M</given-names></name><name><surname>Gingeras</surname><given-names>TR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>STAR: ultrafast universal RNA-seq aligner</article-title><source>Bioinformatics</source><volume>29</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id><pub-id pub-id-type="pmid">23104886</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dyson</surname><given-names>N</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>The regulation of E2F by prb-family proteins</article-title><source>Genes &amp; Development</source><volume>12</volume><fpage>2245</fpage><lpage>2262</lpage><pub-id pub-id-type="doi">10.1101/gad.12.15.2245</pub-id><pub-id pub-id-type="pmid">9694791</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dyson</surname><given-names>NJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>RB1: a prototype tumor suppressor and an enigma</article-title><source>Genes &amp; Development</source><volume>30</volume><fpage>1492</fpage><lpage>1502</lpage><pub-id pub-id-type="doi">10.1101/gad.282145.116</pub-id><pub-id pub-id-type="pmid">27401552</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Español-Suñer</surname><given-names>R</given-names></name><name><surname>Carpentier</surname><given-names>R</given-names></name><name><surname>Van Hul</surname><given-names>N</given-names></name><name><surname>Legry</surname><given-names>V</given-names></name><name><surname>Achouri</surname><given-names>Y</given-names></name><name><surname>Cordi</surname><given-names>S</given-names></name><name><surname>Jacquemin</surname><given-names>P</given-names></name><name><surname>Lemaigre</surname><given-names>F</given-names></name><name><surname>Leclercq</surname><given-names>IA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Liver progenitor cells yield functional hepatocytes in response to chronic liver injury in mice</article-title><source>Gastroenterology</source><volume>143</volume><fpage>1564</fpage><lpage>1575</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2012.08.024</pub-id><pub-id pub-id-type="pmid">22922013</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gadd</surname><given-names>VL</given-names></name><name><surname>Skoien</surname><given-names>R</given-names></name><name><surname>Powell</surname><given-names>EE</given-names></name><name><surname>Fagan</surname><given-names>KJ</given-names></name><name><surname>Winterford</surname><given-names>C</given-names></name><name><surname>Horsfall</surname><given-names>L</given-names></name><name><surname>Irvine</surname><given-names>K</given-names></name><name><surname>Clouston</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease</article-title><source>Hepatology</source><volume>59</volume><fpage>1393</fpage><lpage>1405</lpage><pub-id pub-id-type="doi">10.1002/hep.26937</pub-id><pub-id pub-id-type="pmid">24254368</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gadd</surname><given-names>VL</given-names></name><name><surname>Aleksieva</surname><given-names>N</given-names></name><name><surname>Forbes</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Epithelial plasticity during liver injury and regeneration</article-title><source>Cell Stem Cell</source><volume>27</volume><fpage>557</fpage><lpage>573</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2020.08.016</pub-id><pub-id pub-id-type="pmid">32971004</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hallett</surname><given-names>JM</given-names></name><name><surname>Ferreira-Gonzalez</surname><given-names>S</given-names></name><name><surname>Man</surname><given-names>TY</given-names></name><name><surname>Kilpatrick</surname><given-names>AM</given-names></name><name><surname>Esser</surname><given-names>H</given-names></name><name><surname>Thirlwell</surname><given-names>K</given-names></name><name><surname>Macmillan</surname><given-names>MT</given-names></name><name><surname>Rodrigo-Torres</surname><given-names>D</given-names></name><name><surname>Dwyer</surname><given-names>BJ</given-names></name><name><surname>Gadd</surname><given-names>VL</given-names></name><name><surname>Ashmore-Harris</surname><given-names>C</given-names></name><name><surname>Lu</surname><given-names>WY</given-names></name><name><surname>Thomson</surname><given-names>JP</given-names></name><name><surname>Jansen</surname><given-names>MA</given-names></name><name><surname>O’Duibhir</surname><given-names>E</given-names></name><name><surname>Starkey Lewis</surname><given-names>PJ</given-names></name><name><surname>Campana</surname><given-names>L</given-names></name><name><surname>Aird</surname><given-names>RE</given-names></name><name><surname>Bate</surname><given-names>TSR</given-names></name><name><surname>Fraser</surname><given-names>AR</given-names></name><name><surname>Campbell</surname><given-names>JDM</given-names></name><name><surname>Oniscu</surname><given-names>GC</given-names></name><name><surname>Hay</surname><given-names>DC</given-names></name><name><surname>Callanan</surname><given-names>A</given-names></name><name><surname>Forbes</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Human biliary epithelial cells from discarded donor livers rescue bile duct structure and function in a mouse model of biliary disease</article-title><source>Cell Stem Cell</source><volume>29</volume><fpage>355</fpage><lpage>371</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2022.02.006</pub-id><pub-id pub-id-type="pmid">35245467</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>MCF</given-names></name><name><surname>Das</surname><given-names>D</given-names></name><name><surname>Sambandam</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>MQ</given-names></name><name><surname>Nahlé</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Regulation of the PDK4 isozyme by the RB-E2F1 complex</article-title><source>The Journal of Biological Chemistry</source><volume>283</volume><fpage>27410</fpage><lpage>27417</lpage><pub-id pub-id-type="doi">10.1074/jbc.M802418200</pub-id><pub-id pub-id-type="pmid">18667418</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huber</surname><given-names>K</given-names></name><name><surname>Mestres-Arenas</surname><given-names>A</given-names></name><name><surname>Fajas</surname><given-names>L</given-names></name><name><surname>Leal-Esteban</surname><given-names>LC</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The multifaceted role of cell cycle regulators in the coordination of growth and metabolism</article-title><source>The FEBS Journal</source><volume>288</volume><fpage>3813</fpage><lpage>3833</lpage><pub-id pub-id-type="doi">10.1111/febs.15586</pub-id><pub-id pub-id-type="pmid">33030287</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huch</surname><given-names>M</given-names></name><name><surname>Dorrell</surname><given-names>C</given-names></name><name><surname>Boj</surname><given-names>SF</given-names></name><name><surname>van Es</surname><given-names>JH</given-names></name><name><surname>Li</surname><given-names>VSW</given-names></name><name><surname>van de Wetering</surname><given-names>M</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Hamer</surname><given-names>K</given-names></name><name><surname>Sasaki</surname><given-names>N</given-names></name><name><surname>Finegold</surname><given-names>MJ</given-names></name><name><surname>Haft</surname><given-names>A</given-names></name><name><surname>Vries</surname><given-names>RG</given-names></name><name><surname>Grompe</surname><given-names>M</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>In vitro expansion of single lgr5+ liver stem cells induced by wnt-driven regeneration</article-title><source>Nature</source><volume>494</volume><fpage>247</fpage><lpage>250</lpage><pub-id pub-id-type="doi">10.1038/nature11826</pub-id><pub-id pub-id-type="pmid">23354049</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huch</surname><given-names>M</given-names></name><name><surname>Gehart</surname><given-names>H</given-names></name><name><surname>van Boxtel</surname><given-names>R</given-names></name><name><surname>Hamer</surname><given-names>K</given-names></name><name><surname>Blokzijl</surname><given-names>F</given-names></name><name><surname>Verstegen</surname><given-names>MMA</given-names></name><name><surname>Ellis</surname><given-names>E</given-names></name><name><surname>van Wenum</surname><given-names>M</given-names></name><name><surname>Fuchs</surname><given-names>SA</given-names></name><name><surname>de Ligt</surname><given-names>J</given-names></name><name><surname>van de Wetering</surname><given-names>M</given-names></name><name><surname>Sasaki</surname><given-names>N</given-names></name><name><surname>Boers</surname><given-names>SJ</given-names></name><name><surname>Kemperman</surname><given-names>H</given-names></name><name><surname>de Jonge</surname><given-names>J</given-names></name><name><surname>Ijzermans</surname><given-names>JNM</given-names></name><name><surname>Nieuwenhuis</surname><given-names>EES</given-names></name><name><surname>Hoekstra</surname><given-names>R</given-names></name><name><surname>Strom</surname><given-names>S</given-names></name><name><surname>Vries</surname><given-names>RRG</given-names></name><name><surname>van der Laan</surname><given-names>LJW</given-names></name><name><surname>Cuppen</surname><given-names>E</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Long-term culture of genome-stable bipotent stem cells from adult human liver</article-title><source>Cell</source><volume>160</volume><fpage>299</fpage><lpage>312</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.11.050</pub-id><pub-id pub-id-type="pmid">25533785</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ipsen</surname><given-names>DH</given-names></name><name><surname>Lykkesfeldt</surname><given-names>J</given-names></name><name><surname>Tveden-Nyborg</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease</article-title><source>Cellular and Molecular Life Sciences</source><volume>75</volume><fpage>3313</fpage><lpage>3327</lpage><pub-id pub-id-type="doi">10.1007/s00018-018-2860-6</pub-id><pub-id pub-id-type="pmid">29936596</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lê</surname><given-names>S</given-names></name><name><surname>Josse</surname><given-names>J</given-names></name><name><surname>Husson</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>FactoMineR: an R package for multivariate analysis</article-title><source>J. Stat. Soft</source><volume>25</volume><elocation-id>i01</elocation-id><pub-id pub-id-type="doi">10.18637/jss.v025.i01</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Dorrell</surname><given-names>C</given-names></name><name><surname>Canaday</surname><given-names>PS</given-names></name><name><surname>Pelz</surname><given-names>C</given-names></name><name><surname>Haft</surname><given-names>A</given-names></name><name><surname>Finegold</surname><given-names>M</given-names></name><name><surname>Grompe</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Adult mouse liver contains two distinct populations of cholangiocytes</article-title><source>Stem Cell Reports</source><volume>9</volume><fpage>478</fpage><lpage>489</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2017.06.003</pub-id><pub-id pub-id-type="pmid">28689996</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname><given-names>MI</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>Anders</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with deseq2</article-title><source>Genome Biology</source><volume>15</volume><elocation-id>550</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id><pub-id pub-id-type="pmid">25516281</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>WY</given-names></name><name><surname>Bird</surname><given-names>TG</given-names></name><name><surname>Boulter</surname><given-names>L</given-names></name><name><surname>Tsuchiya</surname><given-names>A</given-names></name><name><surname>Cole</surname><given-names>AM</given-names></name><name><surname>Hay</surname><given-names>T</given-names></name><name><surname>Guest</surname><given-names>RV</given-names></name><name><surname>Wojtacha</surname><given-names>D</given-names></name><name><surname>Man</surname><given-names>TY</given-names></name><name><surname>Mackinnon</surname><given-names>A</given-names></name><name><surname>Ridgway</surname><given-names>RA</given-names></name><name><surname>Kendall</surname><given-names>T</given-names></name><name><surname>Williams</surname><given-names>MJ</given-names></name><name><surname>Jamieson</surname><given-names>T</given-names></name><name><surname>Raven</surname><given-names>A</given-names></name><name><surname>Hay</surname><given-names>DC</given-names></name><name><surname>Iredale</surname><given-names>JP</given-names></name><name><surname>Clarke</surname><given-names>AR</given-names></name><name><surname>Sansom</surname><given-names>OJ</given-names></name><name><surname>Forbes</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Hepatic progenitor cells of biliary origin with liver repopulation capacity</article-title><source>Nature Cell Biology</source><volume>17</volume><fpage>971</fpage><lpage>983</lpage><pub-id pub-id-type="doi">10.1038/ncb3203</pub-id><pub-id pub-id-type="pmid">26192438</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machado</surname><given-names>MV</given-names></name><name><surname>Michelotti</surname><given-names>GA</given-names></name><name><surname>Pereira</surname><given-names>TA</given-names></name><name><surname>Xie</surname><given-names>G</given-names></name><name><surname>Premont</surname><given-names>R</given-names></name><name><surname>Cortez-Pinto</surname><given-names>H</given-names></name><name><surname>Diehl</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Accumulation of duct cells with activated YAP parallels fibrosis progression in non-alcoholic fatty liver disease</article-title><source>Journal of Hepatology</source><volume>63</volume><fpage>962</fpage><lpage>970</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2015.05.031</pub-id><pub-id pub-id-type="pmid">26070409</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malhi</surname><given-names>H</given-names></name><name><surname>Bronk</surname><given-names>SF</given-names></name><name><surname>Werneburg</surname><given-names>NW</given-names></name><name><surname>Gores</surname><given-names>GJ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis</article-title><source>The Journal of Biological Chemistry</source><volume>281</volume><fpage>12093</fpage><lpage>12101</lpage><pub-id pub-id-type="doi">10.1074/jbc.M510660200</pub-id><pub-id pub-id-type="pmid">16505490</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manco</surname><given-names>R</given-names></name><name><surname>Clerbaux</surname><given-names>LA</given-names></name><name><surname>Verhulst</surname><given-names>S</given-names></name><name><surname>Bou Nader</surname><given-names>M</given-names></name><name><surname>Sempoux</surname><given-names>C</given-names></name><name><surname>Ambroise</surname><given-names>J</given-names></name><name><surname>Bearzatto</surname><given-names>B</given-names></name><name><surname>Gala</surname><given-names>JL</given-names></name><name><surname>Horsmans</surname><given-names>Y</given-names></name><name><surname>van Grunsven</surname><given-names>L</given-names></name><name><surname>Desdouets</surname><given-names>C</given-names></name><name><surname>Leclercq</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Reactive cholangiocytes differentiate into proliferative hepatocytes with efficient DNA repair in mice with chronic liver injury</article-title><source>Journal of Hepatology</source><volume>70</volume><fpage>1180</fpage><lpage>1191</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2019.02.003</pub-id><pub-id pub-id-type="pmid">30794890</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>K</given-names></name><name><surname>Morales-Navarrete</surname><given-names>H</given-names></name><name><surname>Seifert</surname><given-names>S</given-names></name><name><surname>Wilsch-Braeuninger</surname><given-names>M</given-names></name><name><surname>Dahmen</surname><given-names>U</given-names></name><name><surname>Tanaka</surname><given-names>EM</given-names></name><name><surname>Brusch</surname><given-names>L</given-names></name><name><surname>Kalaidzidis</surname><given-names>Y</given-names></name><name><surname>Zerial</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Bile canaliculi remodeling activates YAP via the actin cytoskeleton during liver regeneration</article-title><source>Molecular Systems Biology</source><volume>16</volume><elocation-id>e8985</elocation-id><pub-id pub-id-type="doi">10.15252/msb.20198985</pub-id><pub-id pub-id-type="pmid">32090478</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miao</surname><given-names>ZF</given-names></name><name><surname>Adkins-Threats</surname><given-names>M</given-names></name><name><surname>Burclaff</surname><given-names>JR</given-names></name><name><surname>Osaki</surname><given-names>LH</given-names></name><name><surname>Sun</surname><given-names>JX</given-names></name><name><surname>Kefalov</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>ZN</given-names></name><name><surname>Mills</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A metformin-responsive metabolic pathway controls distinct steps in gastric progenitor fate decisions and maturation</article-title><source>Cell Stem Cell</source><volume>26</volume><fpage>910</fpage><lpage>925</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2020.03.006</pub-id><pub-id pub-id-type="pmid">32243780</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michalopoulos</surname><given-names>GK</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The liver is a peculiar organ when it comes to stem cells</article-title><source>The American Journal of Pathology</source><volume>184</volume><fpage>1263</fpage><lpage>1267</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2014.02.020</pub-id><pub-id pub-id-type="pmid">24681248</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyajima</surname><given-names>A</given-names></name><name><surname>Tanaka</surname><given-names>M</given-names></name><name><surname>Itoh</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Stem/progenitor cells in liver development, homeostasis, regeneration, and reprogramming</article-title><source>Cell Stem Cell</source><volume>14</volume><fpage>561</fpage><lpage>574</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2014.04.010</pub-id><pub-id pub-id-type="pmid">24792114</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicolay</surname><given-names>BN</given-names></name><name><surname>Dyson</surname><given-names>NJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The multiple connections between prb and cell metabolism</article-title><source>Current Opinion in Cell Biology</source><volume>25</volume><fpage>735</fpage><lpage>740</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2013.07.012</pub-id><pub-id pub-id-type="pmid">23916769</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okabe</surname><given-names>M</given-names></name><name><surname>Tsukahara</surname><given-names>Y</given-names></name><name><surname>Tanaka</surname><given-names>M</given-names></name><name><surname>Suzuki</surname><given-names>K</given-names></name><name><surname>Saito</surname><given-names>S</given-names></name><name><surname>Kamiya</surname><given-names>Y</given-names></name><name><surname>Tsujimura</surname><given-names>T</given-names></name><name><surname>Nakamura</surname><given-names>K</given-names></name><name><surname>Miyajima</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Potential hepatic stem cells reside in epcam+ cells of normal and injured mouse liver</article-title><source>Development</source><volume>136</volume><fpage>1951</fpage><lpage>1960</lpage><pub-id pub-id-type="doi">10.1242/dev.031369</pub-id><pub-id pub-id-type="pmid">19429791</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paschos</surname><given-names>P</given-names></name><name><surname>Paletas</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Non alcoholic fatty liver disease and metabolic syndrome</article-title><source>Hippokratia</source><volume>13</volume><fpage>9</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">19240815</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pepe-Mooney</surname><given-names>BJ</given-names></name><name><surname>Dill</surname><given-names>MT</given-names></name><name><surname>Alemany</surname><given-names>A</given-names></name><name><surname>Ordovas-Montanes</surname><given-names>J</given-names></name><name><surname>Matsushita</surname><given-names>Y</given-names></name><name><surname>Rao</surname><given-names>A</given-names></name><name><surname>Sen</surname><given-names>A</given-names></name><name><surname>Miyazaki</surname><given-names>M</given-names></name><name><surname>Anakk</surname><given-names>S</given-names></name><name><surname>Dawson</surname><given-names>PA</given-names></name><name><surname>Ono</surname><given-names>N</given-names></name><name><surname>Shalek</surname><given-names>AK</given-names></name><name><surname>van Oudenaarden</surname><given-names>A</given-names></name><name><surname>Camargo</surname><given-names>FD</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Single-cell analysis of the liver epithelium reveals dynamic heterogeneity and an essential role for YAP in homeostasis and regeneration</article-title><source>Cell Stem Cell</source><volume>25</volume><fpage>23</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2019.04.004</pub-id><pub-id pub-id-type="pmid">31080134</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Planas-Paz</surname><given-names>L</given-names></name><name><surname>Sun</surname><given-names>T</given-names></name><name><surname>Pikiolek</surname><given-names>M</given-names></name><name><surname>Cochran</surname><given-names>NR</given-names></name><name><surname>Bergling</surname><given-names>S</given-names></name><name><surname>Orsini</surname><given-names>V</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Sigoillot</surname><given-names>F</given-names></name><name><surname>Jetzer</surname><given-names>J</given-names></name><name><surname>Syed</surname><given-names>M</given-names></name><name><surname>Neri</surname><given-names>M</given-names></name><name><surname>Schuierer</surname><given-names>S</given-names></name><name><surname>Morelli</surname><given-names>L</given-names></name><name><surname>Hoppe</surname><given-names>PS</given-names></name><name><surname>Schwarzer</surname><given-names>W</given-names></name><name><surname>Cobos</surname><given-names>CM</given-names></name><name><surname>Alford</surname><given-names>JL</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Cuttat</surname><given-names>R</given-names></name><name><surname>Waldt</surname><given-names>A</given-names></name><name><surname>Carballido-Perrig</surname><given-names>N</given-names></name><name><surname>Nigsch</surname><given-names>F</given-names></name><name><surname>Kinzel</surname><given-names>B</given-names></name><name><surname>Nicholson</surname><given-names>TB</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Mao</surname><given-names>X</given-names></name><name><surname>Terracciano</surname><given-names>LM</given-names></name><name><surname>Russ</surname><given-names>C</given-names></name><name><surname>Reece-Hoyes</surname><given-names>JS</given-names></name><name><surname>Gubser Keller</surname><given-names>C</given-names></name><name><surname>Sailer</surname><given-names>AW</given-names></name><name><surname>Bouwmeester</surname><given-names>T</given-names></name><name><surname>Greenbaum</surname><given-names>LE</given-names></name><name><surname>Lugus</surname><given-names>JJ</given-names></name><name><surname>Cong</surname><given-names>F</given-names></name><name><surname>McAllister</surname><given-names>G</given-names></name><name><surname>Hoffman</surname><given-names>GR</given-names></name><name><surname>Roma</surname><given-names>G</given-names></name><name><surname>Tchorz</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>YAP, but not rspo-lgr4/5, signaling in biliary epithelial cells promotes a ductular reaction in response to liver injury</article-title><source>Cell Stem Cell</source><volume>25</volume><fpage>39</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2019.04.005</pub-id><pub-id pub-id-type="pmid">31080135</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raven</surname><given-names>A</given-names></name><name><surname>Lu</surname><given-names>W-Y</given-names></name><name><surname>Man</surname><given-names>TY</given-names></name><name><surname>Ferreira-Gonzalez</surname><given-names>S</given-names></name><name><surname>O’Duibhir</surname><given-names>E</given-names></name><name><surname>Dwyer</surname><given-names>BJ</given-names></name><name><surname>Thomson</surname><given-names>JP</given-names></name><name><surname>Meehan</surname><given-names>RR</given-names></name><name><surname>Bogorad</surname><given-names>R</given-names></name><name><surname>Koteliansky</surname><given-names>V</given-names></name><name><surname>Kotelevtsev</surname><given-names>Y</given-names></name><name><surname>Ffrench-Constant</surname><given-names>C</given-names></name><name><surname>Boulter</surname><given-names>L</given-names></name><name><surname>Forbes</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Cholangiocytes act as facultative liver stem cells during impaired hepatocyte regeneration</article-title><source>Nature</source><volume>547</volume><fpage>350</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.1038/nature23015</pub-id><pub-id pub-id-type="pmid">28700576</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>B</given-names></name><name><surname>Cam</surname><given-names>H</given-names></name><name><surname>Takahashi</surname><given-names>Y</given-names></name><name><surname>Volkert</surname><given-names>T</given-names></name><name><surname>Terragni</surname><given-names>J</given-names></name><name><surname>Young</surname><given-names>RA</given-names></name><name><surname>Dynlacht</surname><given-names>BD</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints</article-title><source>Genes &amp; Development</source><volume>16</volume><fpage>245</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1101/gad.949802</pub-id><pub-id pub-id-type="pmid">11799067</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodrigo-Torres</surname><given-names>D</given-names></name><name><surname>Affò</surname><given-names>S</given-names></name><name><surname>Coll</surname><given-names>M</given-names></name><name><surname>Morales-Ibanez</surname><given-names>O</given-names></name><name><surname>Millán</surname><given-names>C</given-names></name><name><surname>Blaya</surname><given-names>D</given-names></name><name><surname>Alvarez-Guaita</surname><given-names>A</given-names></name><name><surname>Rentero</surname><given-names>C</given-names></name><name><surname>Lozano</surname><given-names>JJ</given-names></name><name><surname>Maestro</surname><given-names>MA</given-names></name><name><surname>Solar</surname><given-names>M</given-names></name><name><surname>Arroyo</surname><given-names>V</given-names></name><name><surname>Caballería</surname><given-names>J</given-names></name><name><surname>van Grunsven</surname><given-names>LA</given-names></name><name><surname>Enrich</surname><given-names>C</given-names></name><name><surname>Ginès</surname><given-names>P</given-names></name><name><surname>Bataller</surname><given-names>R</given-names></name><name><surname>Sancho-Bru</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The biliary epithelium gives rise to liver progenitor cells</article-title><source>Hepatology</source><volume>60</volume><fpage>1367</fpage><lpage>1377</lpage><pub-id pub-id-type="doi">10.1002/hep.27078</pub-id><pub-id pub-id-type="pmid">24700364</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname><given-names>JO</given-names></name><name><surname>Lu</surname><given-names>WY</given-names></name><name><surname>Okabe</surname><given-names>H</given-names></name><name><surname>Abrams</surname><given-names>M</given-names></name><name><surname>Oertel</surname><given-names>M</given-names></name><name><surname>Poddar</surname><given-names>M</given-names></name><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Forbes</surname><given-names>SJ</given-names></name><name><surname>Monga</surname><given-names>SP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Hepatocyte-specific β-catenin deletion during severe liver injury provokes cholangiocytes to differentiate into hepatocytes</article-title><source>Hepatology</source><volume>69</volume><fpage>742</fpage><lpage>759</lpage><pub-id pub-id-type="doi">10.1002/hep.30270</pub-id><pub-id pub-id-type="pmid">30215850</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sampaziotis</surname><given-names>F</given-names></name><name><surname>Muraro</surname><given-names>D</given-names></name><name><surname>Tysoe</surname><given-names>OC</given-names></name><name><surname>Sawiak</surname><given-names>S</given-names></name><name><surname>Beach</surname><given-names>TE</given-names></name><name><surname>Godfrey</surname><given-names>EM</given-names></name><name><surname>Upponi</surname><given-names>SS</given-names></name><name><surname>Brevini</surname><given-names>T</given-names></name><name><surname>Wesley</surname><given-names>BT</given-names></name><name><surname>Garcia-Bernardo</surname><given-names>J</given-names></name><name><surname>Mahbubani</surname><given-names>K</given-names></name><name><surname>Canu</surname><given-names>G</given-names></name><name><surname>Gieseck</surname><given-names>R</given-names></name><name><surname>Berntsen</surname><given-names>NL</given-names></name><name><surname>Mulcahy</surname><given-names>VL</given-names></name><name><surname>Crick</surname><given-names>K</given-names></name><name><surname>Fear</surname><given-names>C</given-names></name><name><surname>Robinson</surname><given-names>S</given-names></name><name><surname>Swift</surname><given-names>L</given-names></name><name><surname>Gambardella</surname><given-names>L</given-names></name><name><surname>Bargehr</surname><given-names>J</given-names></name><name><surname>Ortmann</surname><given-names>D</given-names></name><name><surname>Brown</surname><given-names>SE</given-names></name><name><surname>Osnato</surname><given-names>A</given-names></name><name><surname>Murphy</surname><given-names>MP</given-names></name><name><surname>Corbett</surname><given-names>G</given-names></name><name><surname>Gelson</surname><given-names>WTH</given-names></name><name><surname>Mells</surname><given-names>GF</given-names></name><name><surname>Humphreys</surname><given-names>P</given-names></name><name><surname>Davies</surname><given-names>SE</given-names></name><name><surname>Amin</surname><given-names>I</given-names></name><name><surname>Gibbs</surname><given-names>P</given-names></name><name><surname>Sinha</surname><given-names>S</given-names></name><name><surname>Teichmann</surname><given-names>SA</given-names></name><name><surname>Butler</surname><given-names>AJ</given-names></name><name><surname>See</surname><given-names>TC</given-names></name><name><surname>Melum</surname><given-names>E</given-names></name><name><surname>Watson</surname><given-names>CJE</given-names></name><name><surname>Saeb-Parsy</surname><given-names>K</given-names></name><name><surname>Vallier</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Cholangiocyte organoids can repair bile ducts after transplantation in the human liver</article-title><source>Science</source><volume>371</volume><fpage>839</fpage><lpage>846</lpage><pub-id pub-id-type="doi">10.1126/science.aaz6964</pub-id><pub-id pub-id-type="pmid">33602855</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sano</surname><given-names>A</given-names></name><name><surname>Kakazu</surname><given-names>E</given-names></name><name><surname>Hamada</surname><given-names>S</given-names></name><name><surname>Inoue</surname><given-names>J</given-names></name><name><surname>Ninomiya</surname><given-names>M</given-names></name><name><surname>Iwata</surname><given-names>T</given-names></name><name><surname>Tsuruoka</surname><given-names>M</given-names></name><name><surname>Sato</surname><given-names>K</given-names></name><name><surname>Masamune</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Steatotic hepatocytes release mature VLDL through methionine and tyrosine metabolism in a keap1-nrf2-dependent manner</article-title><source>Hepatology</source><volume>74</volume><fpage>1271</fpage><lpage>1286</lpage><pub-id pub-id-type="doi">10.1002/hep.31808</pub-id><pub-id pub-id-type="pmid">33724516</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>K</given-names></name><name><surname>Marzioni</surname><given-names>M</given-names></name><name><surname>Meng</surname><given-names>F</given-names></name><name><surname>Francis</surname><given-names>H</given-names></name><name><surname>Glaser</surname><given-names>S</given-names></name><name><surname>Alpini</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Ductular reaction in liver diseases: pathological mechanisms and translational significances</article-title><source>Hepatology</source><volume>69</volume><fpage>420</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.1002/hep.30150</pub-id><pub-id pub-id-type="pmid">30070383</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schindelin</surname><given-names>J</given-names></name><name><surname>Arganda-Carreras</surname><given-names>I</given-names></name><name><surname>Frise</surname><given-names>E</given-names></name><name><surname>Kaynig</surname><given-names>V</given-names></name><name><surname>Longair</surname><given-names>M</given-names></name><name><surname>Pietzsch</surname><given-names>T</given-names></name><name><surname>Preibisch</surname><given-names>S</given-names></name><name><surname>Rueden</surname><given-names>C</given-names></name><name><surname>Saalfeld</surname><given-names>S</given-names></name><name><surname>Schmid</surname><given-names>B</given-names></name><name><surname>Tinevez</surname><given-names>JY</given-names></name><name><surname>White</surname><given-names>DJ</given-names></name><name><surname>Hartenstein</surname><given-names>V</given-names></name><name><surname>Eliceiri</surname><given-names>K</given-names></name><name><surname>Tomancak</surname><given-names>P</given-names></name><name><surname>Cardona</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fiji: an open-source platform for biological-image analysis</article-title><source>Nature Methods</source><volume>9</volume><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id><pub-id pub-id-type="pmid">22743772</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>S</given-names></name><name><surname>Walton</surname><given-names>G</given-names></name><name><surname>Aoki</surname><given-names>R</given-names></name><name><surname>Brondell</surname><given-names>K</given-names></name><name><surname>Schug</surname><given-names>J</given-names></name><name><surname>Fox</surname><given-names>A</given-names></name><name><surname>Smirnova</surname><given-names>O</given-names></name><name><surname>Dorrell</surname><given-names>C</given-names></name><name><surname>Erker</surname><given-names>L</given-names></name><name><surname>Chu</surname><given-names>AS</given-names></name><name><surname>Wells</surname><given-names>RG</given-names></name><name><surname>Grompe</surname><given-names>M</given-names></name><name><surname>Greenbaum</surname><given-names>LE</given-names></name><name><surname>Kaestner</surname><given-names>KH</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Foxl1-cre-marked adult hepatic progenitors have clonogenic and bilineage differentiation potential</article-title><source>Genes &amp; Development</source><volume>25</volume><fpage>1185</fpage><lpage>1192</lpage><pub-id pub-id-type="doi">10.1101/gad.2027811</pub-id><pub-id pub-id-type="pmid">21632825</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sorrentino</surname><given-names>P</given-names></name><name><surname>Tarantino</surname><given-names>G</given-names></name><name><surname>Perrella</surname><given-names>A</given-names></name><name><surname>Micheli</surname><given-names>P</given-names></name><name><surname>Perrella</surname><given-names>O</given-names></name><name><surname>Conca</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>A clinical-morphological study on cholestatic presentation of nonalcoholic fatty liver disease</article-title><source>Digestive Diseases and Sciences</source><volume>50</volume><fpage>1130</fpage><lpage>1135</lpage><pub-id pub-id-type="doi">10.1007/s10620-005-2719-1</pub-id><pub-id pub-id-type="pmid">15986869</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sorrentino</surname><given-names>G</given-names></name><name><surname>Rezakhani</surname><given-names>S</given-names></name><name><surname>Yildiz</surname><given-names>E</given-names></name><name><surname>Nuciforo</surname><given-names>S</given-names></name><name><surname>Heim</surname><given-names>MH</given-names></name><name><surname>Lutolf</surname><given-names>MP</given-names></name><name><surname>Schoonjans</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Mechano-modulatory synthetic niches for liver organoid derivation</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>3416</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-17161-0</pub-id><pub-id pub-id-type="pmid">32651372</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuchiya</surname><given-names>A</given-names></name><name><surname>Lu</surname><given-names>WY</given-names></name><name><surname>Weinhold</surname><given-names>B</given-names></name><name><surname>Boulter</surname><given-names>L</given-names></name><name><surname>Stutchfield</surname><given-names>BM</given-names></name><name><surname>Williams</surname><given-names>MJ</given-names></name><name><surname>Guest</surname><given-names>RV</given-names></name><name><surname>Minnis-Lyons</surname><given-names>SE</given-names></name><name><surname>MacKinnon</surname><given-names>AC</given-names></name><name><surname>Schwarzer</surname><given-names>D</given-names></name><name><surname>Ichida</surname><given-names>T</given-names></name><name><surname>Nomoto</surname><given-names>M</given-names></name><name><surname>Aoyagi</surname><given-names>Y</given-names></name><name><surname>Gerardy-Schahn</surname><given-names>R</given-names></name><name><surname>Forbes</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Polysialic acid/neural cell adhesion molecule modulates the formation of ductular reactions in liver injury</article-title><source>Hepatology</source><volume>60</volume><fpage>1727</fpage><lpage>1740</lpage><pub-id pub-id-type="doi">10.1002/hep.27099</pub-id><pub-id pub-id-type="pmid">24585441</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vander Heiden</surname><given-names>MG</given-names></name><name><surname>Cantley</surname><given-names>LC</given-names></name><name><surname>Thompson</surname><given-names>CB</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Understanding the warburg effect: the metabolic requirements of cell proliferation</article-title><source>Science</source><volume>324</volume><fpage>1029</fpage><lpage>1033</lpage><pub-id pub-id-type="doi">10.1126/science.1160809</pub-id><pub-id pub-id-type="pmid">19460998</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>LY</given-names></name><name><surname>Hung</surname><given-names>CL</given-names></name><name><surname>Chen</surname><given-names>YR</given-names></name><name><surname>Yang</surname><given-names>JC</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Campbell</surname><given-names>M</given-names></name><name><surname>Izumiya</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>HW</given-names></name><name><surname>Wang</surname><given-names>WC</given-names></name><name><surname>Ann</surname><given-names>DK</given-names></name><name><surname>Kung</surname><given-names>HJ</given-names></name></person-group><year iso-8601-date="2016">2016a</year><article-title>KDM4A coactivates E2F1 to regulate the PDK-dependent metabolic switch between mitochondrial oxidation and glycolysis</article-title><source>Cell Reports</source><volume>16</volume><fpage>3016</fpage><lpage>3027</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.08.018</pub-id><pub-id pub-id-type="pmid">27626669</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Zheng</surname><given-names>Z</given-names></name><name><surname>Caviglia</surname><given-names>JM</given-names></name><name><surname>Corey</surname><given-names>KE</given-names></name><name><surname>Herfel</surname><given-names>TM</given-names></name><name><surname>Cai</surname><given-names>B</given-names></name><name><surname>Masia</surname><given-names>R</given-names></name><name><surname>Chung</surname><given-names>RT</given-names></name><name><surname>Lefkowitch</surname><given-names>JH</given-names></name><name><surname>Schwabe</surname><given-names>RF</given-names></name><name><surname>Tabas</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2016">2016b</year><article-title>Hepatocyte TAZ/WWTR1 promotes inflammation and fibrosis in nonalcoholic steatohepatitis</article-title><source>Cell Metabolism</source><volume>24</volume><fpage>848</fpage><lpage>862</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2016.09.016</pub-id><pub-id pub-id-type="pmid">28068223</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Wickham</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2016">2016</year><source>Ggplot2: Elegant Graphics for Data Analysis</source><publisher-name>springer</publisher-name><pub-id pub-id-type="doi">10.1007/978-3-319-24277-4</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wobser</surname><given-names>H</given-names></name><name><surname>Dorn</surname><given-names>C</given-names></name><name><surname>Weiss</surname><given-names>TS</given-names></name><name><surname>Amann</surname><given-names>T</given-names></name><name><surname>Bollheimer</surname><given-names>C</given-names></name><name><surname>Büttner</surname><given-names>R</given-names></name><name><surname>Schölmerich</surname><given-names>J</given-names></name><name><surname>Hellerbrand</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells</article-title><source>Cell Research</source><volume>19</volume><fpage>996</fpage><lpage>1005</lpage><pub-id pub-id-type="doi">10.1038/cr.2009.73</pub-id><pub-id pub-id-type="pmid">19546889</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yanger</surname><given-names>K</given-names></name><name><surname>Stanger</surname><given-names>BZ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Facultative stem cells in liver and pancreas: fact and fancy</article-title><source>Developmental Dynamics</source><volume>240</volume><fpage>521</fpage><lpage>529</lpage><pub-id pub-id-type="doi">10.1002/dvdy.22561</pub-id><pub-id pub-id-type="pmid">21312313</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>LG</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>QY</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>ClusterProfiler: an R package for comparing biological themes among gene clusters</article-title><source>OMICS</source><volume>16</volume><fpage>284</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1089/omi.2011.0118</pub-id><pub-id pub-id-type="pmid">22455463</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Ryu</surname><given-names>D</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Gariani</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Luan</surname><given-names>P</given-names></name><name><surname>D’Amico</surname><given-names>D</given-names></name><name><surname>Ropelle</surname><given-names>ER</given-names></name><name><surname>Lutolf</surname><given-names>MP</given-names></name><name><surname>Aebersold</surname><given-names>R</given-names></name><name><surname>Schoonjans</surname><given-names>K</given-names></name><name><surname>Menzies</surname><given-names>KJ</given-names></name><name><surname>Auwerx</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>NADNAD</article-title><source>Science</source><volume>352</volume><fpage>1436</fpage><lpage>1443</lpage><pub-id pub-id-type="doi">10.1126/science.aaf2693</pub-id><pub-id pub-id-type="pmid">27127236</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><table-wrap id="app1keyresource" position="anchor"><label>Appendix 1—key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-mouse CD45–PE/Cy7 (Rat monoclonal)</td><td align="left" valign="bottom">BD Biosciences</td><td align="char" char="." valign="bottom">552848</td><td align="left" valign="bottom">FACS, Flow cytometry (1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-mouse CD11b–PE/Cy7 (Rat monoclonal)</td><td align="left" valign="bottom">BD Biosciences</td><td align="char" char="." valign="bottom">552850</td><td align="left" valign="bottom">FACS, Flow cytometry (1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-mouse/human CD31–PE/Cy7<break/>(Rat monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab46733</td><td align="left" valign="bottom">FACS (1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-mouse CD31–PE/Cy7<break/>(Rat monoclonal)</td><td align="left" valign="bottom">BD Biosciences</td><td align="char" char="." valign="bottom">561410</td><td align="left" valign="bottom">FACS, Flow cytometry (1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-mouse EPCAM–APC (Rat monoclonal)</td><td align="left" valign="bottom">eBioscience</td><td align="char" char="hyphen" valign="bottom">17-5791-82</td><td align="left" valign="bottom">FACS (1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-mouse<break/>EPCAM–VioBlue<break/>(Rat monoclonal)</td><td align="left" valign="bottom">Miltenyi Biotec</td><td align="char" char="hyphen" valign="bottom">130-123-871</td><td align="left" valign="bottom">Flow cytometry (1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Ki67<break/>(Rabbit monoclonal)</td><td align="left" valign="bottom">ThermoFisher</td><td align="left" valign="bottom">MA5-14520</td><td align="left" valign="bottom">IF (1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-PANCK<break/>(Rabbit polyclonal)</td><td align="left" valign="bottom">Novusbio</td><td align="left" valign="bottom">NBP600-579</td><td align="left" valign="bottom">IF (1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-OPN<break/>(Goat polyclonal)</td><td align="left" valign="bottom">R&amp;D Systems</td><td align="left" valign="bottom">AF808</td><td align="left" valign="bottom">IF (1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Cleaved caspase 3<break/>(Rabbit polyclonal)</td><td align="left" valign="bottom">Cell Signaling</td><td align="char" char="." valign="bottom">9661</td><td align="left" valign="bottom">IF (1:100)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Alexa Fluor Phalloidin 488</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">A12379</td><td align="left" valign="bottom">IF (1:1000)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">BODIPY 558/568</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">D38D35</td><td align="left" valign="bottom">IF (5 µM)<break/>FACS (40 nM)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom"><italic>N</italic>-acetylcysteine</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">A9165</td><td align="char" char="." valign="bottom">(1 mM)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Nicotinamide</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">N0636</td><td align="char" char="." valign="bottom">(10  mM)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Y-27632</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Y0503</td><td align="left" valign="bottom">(10 μM)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">HLM006474</td><td align="left" valign="bottom">Merck</td><td align="char" char="." valign="bottom">324461</td><td align="left" valign="bottom">(10 μM)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Oligomycin</td><td align="left" valign="bottom">Millipore</td><td align="char" char="." valign="bottom">495455</td><td align="left" valign="bottom">(5 μM)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">FCCP</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">C2920</td><td align="left" valign="bottom">(2.5 μM)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Rotenone</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">R8875</td><td align="left" valign="bottom">(1 μM)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Antimycin A</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">A8674</td><td align="left" valign="bottom">(1 μM)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="char" char="hyphen" valign="bottom">2-DG</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">D8375</td><td align="char" char="." valign="bottom">(50 mM)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">UK5099</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PZ0160</td><td align="left" valign="bottom">(2 μM)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Etomoxir</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">E1905</td><td align="left" valign="bottom">(4 μM)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">BPTES</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">SML0601</td><td align="left" valign="bottom">(3 μM)</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Anti-rabbit IgG Polymer Detection Kit (ImmpRESS Horse HRP conjugated secondary)</td><td align="left" valign="bottom">VectorLabs</td><td align="left" valign="bottom">MP-74-01-15</td><td align="left" valign="bottom">IF (100 µl) per tissue section</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Anti-mouse IgG Polymer Detection Kit (ImmpRESS Horse HRP conjugated secondary)</td><td align="left" valign="bottom">VectorLabs</td><td align="left" valign="bottom">MP-74-02-15</td><td align="left" valign="bottom">IF (100 µl) per tissue section</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Click-iT EdU Alexa Fluor 647</td><td align="left" valign="bottom">ThermoFisher</td><td align="left" valign="bottom">Cat. # C10340</td><td align="left" valign="bottom">(50 μg per g of mouse weight)</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">EdU Alexa Fluor 488</td><td align="left" valign="bottom">ThermoFisher</td><td align="left" valign="bottom">C10425</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">MT Cell Viability Assay</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">G9711</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">RNeasy micro kit</td><td align="left" valign="bottom">QIAGEN</td><td align="char" char="." valign="bottom">74104</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">RNAqueous total RNA isolation kit</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">AM1931</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">QuantiTect Reverse Transcription Kit</td><td align="left" valign="bottom">Qiagen</td><td align="char" char="." valign="bottom">205314</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">SYBR Green</td><td align="left" valign="bottom">Roche</td><td align="char" char="." valign="bottom">4887352001</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Triglyceride kit</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab65336</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Cell-titer Glo</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">G7570</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Caspase 3/7 activity</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">G8091</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Nucgreen Dead 488</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">R37109</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">Gastrin</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">G9145</td><td align="char" char="." valign="bottom">(10 nM)</td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">EGF</td><td align="left" valign="bottom">Peprotech</td><td align="left" valign="bottom">AF-100–15</td><td align="char" char="." valign="bottom">(50  ng/ml)</td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">FGF10</td><td align="left" valign="bottom">Peprotech</td><td align="char" char="." valign="bottom">100–26</td><td align="char" char="." valign="bottom">(100  ng/ml)</td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">HGF</td><td align="left" valign="bottom">Peprotech</td><td align="char" char="." valign="bottom">100–39</td><td align="char" char="." valign="bottom">(50  ng/ml)</td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">Wnt3a</td><td align="left" valign="bottom">Peprotech</td><td align="char" char="." valign="bottom">315–20</td><td align="left" valign="bottom">(1 µg/ml)</td></tr><tr><td align="left" valign="bottom">Strain, strain background<break/>(<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">C57BL/6JRj</td><td align="left" valign="bottom">Janvier Labs</td><td align="left" valign="bottom">C57BL/6JRj</td><td align="left" valign="bottom">Males, 8-week-old</td></tr><tr><td align="left" valign="bottom">Strain, strain background<break/>(<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>E2f1<sup>+/+</sup></italic> and <italic>E2f1<sup>-/-</sup></italic></td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="char" char="." valign="bottom">(B6;129S4-E2f1tm1 Meg/J)</td><td align="left" valign="bottom">Males, 8-week-old</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">FlowJo</td><td align="left" valign="bottom">FlowJo</td><td align="left" valign="bottom">v10.8</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Prism</td><td align="left" valign="bottom">GraphPad</td><td align="left" valign="bottom">Prism 9</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">STAR</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib18">Dobin et al., 2013</xref></td><td align="left" valign="bottom">version 2.6.0 a</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">DESeq2</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib32">Love et al., 2014</xref></td><td align="left" valign="bottom">version 1.34.0</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">clusterProfiler</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib64">Yu et al., 2012</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ggplot2</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib61">Wickham, 2016</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">QuPath</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib5">Bankhead et al., 2017</xref></td><td align="left" valign="bottom">version<break/>0.2.3</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Fiji</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib53">Schindelin et al., 2012</xref></td><td align="left" valign="bottom">version<break/>2.3.0</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Chow Diet</td><td align="left" valign="bottom">SAFE</td><td align="left" valign="bottom">SAFE 150</td><td align="left" valign="bottom">Section ‘Mouse studies and ethical approval’ For C57BL/6JRj</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">High Fat Diet</td><td align="left" valign="bottom">Research Diets Inc</td><td align="left" valign="bottom">D12492i</td><td align="left" valign="bottom">Section ‘Mouse studies and ethical approval’ For C57BL/6JRj</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Chow Diet</td><td align="left" valign="bottom">Kliba Nafag</td><td align="char" char="." valign="bottom">3336</td><td align="left" valign="bottom">Section ‘Mouse studies and ethical approval’ For E<italic>2f1<sup>+/+</sup></italic> and <italic>E2f1<sup>-/-</sup></italic></td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">High Fat Diet</td><td align="left" valign="bottom">Envigo</td><td align="left" valign="bottom">TD93075</td><td align="left" valign="bottom">Section ‘Mouse studies and ethical approval’ For E<italic>2f1<sup>+/+</sup></italic> and <italic>E2f1<sup>-/-</sup></italic></td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">BEC-organoids from mouse</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">Original protocol: <xref ref-type="bibr" rid="bib9">Broutier et al., 2016</xref></td><td align="left" valign="bottom">Section ‘Culture of mouse liver BEC-organoids from single bile duct cells of digested livers’</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">DMEM/Glutamax</td><td align="left" valign="bottom">ThermoFisher</td><td align="char" char="." valign="bottom">31966–021</td><td align="left" valign="bottom">Section ‘EPCAM<sup>+</sup> BEC isolation, FACS, and flow cytometry analysis’</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Collagenase</td><td align="left" valign="bottom">Merck/Sigma</td><td align="left" valign="bottom">C9407</td><td align="left" valign="bottom">Section ‘EPCAM<sup>+</sup> BEC isolation, FACS, and flow cytometry analysis’</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Advanced DMEM/F-12</td><td align="left" valign="bottom">GIBCO</td><td align="char" char="." valign="bottom">12634010</td><td align="left" valign="bottom">Section ‘EPCAM<sup>+</sup> BEC isolation, FACS, and flow cytometry analysis’</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Glutamax</td><td align="left" valign="bottom">ThermoFisher</td><td align="char" char="." valign="bottom">35050061</td><td align="left" valign="bottom">Section ‘EPCAM<sup>+</sup> BEC isolation, FACS, and flow cytometry analysis’</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">HEPES</td><td align="left" valign="bottom">ThermoFisher</td><td align="char" char="." valign="bottom">15630–056</td><td align="left" valign="bottom">Section ‘EPCAM<sup>+</sup> BEC isolation, FACS, and flow cytometry analysis’</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Penicillin/Streptomycin</td><td align="left" valign="bottom">ThermoFisher</td><td align="char" char="." valign="bottom">15140–122</td><td align="left" valign="bottom">Section ‘EPCAM<sup>+</sup> BEC isolation, FACS, and flow cytometry analysis’</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Dispase II</td><td align="left" valign="bottom">ThermoFisher</td><td align="char" char="." valign="bottom">17105–041</td><td align="left" valign="bottom">Section ‘EPCAM<sup>+</sup> BEC isolation, FACS, and flow cytometry analysis’</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">DNAase</td><td align="left" valign="bottom">Merck/Sigma</td><td align="left" valign="bottom">DN25</td><td align="left" valign="bottom">Section ‘EPCAM<sup>+</sup> BEC isolation, FACS, and flow cytometry analysis’</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom"><italic>E2f1</italic><break/>ON-TARGETplus siRNAs</td><td align="left" valign="bottom">Horizon</td><td align="left" valign="bottom">L-044993-00-0005</td><td align="left" valign="bottom">Section ‘Silencing of E2F1 in EPCAM<sup>+</sup> BECs and organoid formation’</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Scrambled<break/>ON-TARGETplus siRNAs</td><td align="left" valign="bottom">Horizon</td><td align="left" valign="bottom">D-001810-10-05</td><td align="left" valign="bottom">Section ‘Silencing of E2F1 in EPCAM<sup>+</sup> BECs and organoid formation’</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">TransIT-X2</td><td align="left" valign="bottom">Mirus</td><td align="left" valign="bottom">MIR6000</td><td align="left" valign="bottom">Section ‘Silencing of E2F1 in EPCAM<sup>+</sup> BECs and organoid formation’</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Matrigel</td><td align="left" valign="bottom">Corning</td><td align="char" char="." valign="bottom">356231</td><td align="left" valign="bottom">Section ‘Culture of mouse liver BEC-organoids from single bile duct cells of digested livers’</td></tr><tr><td align="left" valign="bottom">Other</td><td align="char" char="." valign="bottom">1 X B27</td><td align="left" valign="bottom">Gibco</td><td align="char" char="." valign="bottom">17504044</td><td align="left" valign="bottom">Section ‘Culture of mouse liver BEC-organoids from single bile duct cells of digested livers’</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">TrypLE</td><td align="left" valign="bottom">GIBCO</td><td align="char" char="." valign="bottom">12605028</td><td align="left" valign="bottom">Section ‘Culture of mouse liver BEC-organoids from single bile duct cells of digested livers’</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Palmitic acid</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">P0500</td><td align="left" valign="bottom">Section ‘Culture of mouse liver BEC-organoids from single bile duct cells of digested livers’</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Oleic acid</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">O1008</td><td align="left" valign="bottom">Section ‘Culture of mouse liver BEC-organoids from single bile duct cells of digested livers’</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">DAPI</td><td align="left" valign="bottom">ThermoFisher</td><td align="char" char="." valign="bottom">62248</td><td align="left" valign="bottom">Section ‘Liver immunohistochemistry (IHC) and immunofluorescence (IF)’</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Cell Recovery Solution</td><td align="left" valign="bottom">Corning</td><td align="char" char="." valign="bottom">354253</td><td align="left" valign="bottom">Section ‘BEC-organoid whole-mount immunofluorescence’</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Glucose</td><td align="left" valign="bottom">Agilent</td><td align="char" char="." valign="bottom">103577–100</td><td align="left" valign="bottom">Section ‘Bioenergetics with Seahorse extracellular flux analyzer’</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Pyruvate</td><td align="left" valign="bottom">Gibco</td><td align="char" char="." valign="bottom">11360070</td><td align="left" valign="bottom">Section ‘Bioenergetics with Seahorse extracellular flux analyzer’</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Glutamine</td><td align="left" valign="bottom">Agilent</td><td align="char" char="." valign="bottom">103579–100</td><td align="left" valign="bottom">Section ‘Bioenergetics with Seahorse extracellular flux analyzer’</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Hoechst</td><td align="left" valign="bottom">ThermoFisher</td><td align="char" char="." valign="bottom">62249</td><td align="left" valign="bottom">Section ‘Bioenergetics with Seahorse extracellular flux analyzer’</td></tr></tbody></table></table-wrap></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.81926.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tontonoz</surname><given-names>Peter</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/046rm7j60</institution-id><institution>University of California, Los Angeles</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2022.07.26.501569" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2022.07.26.501569"/></front-stub><body><p>This important study reports that a high-fat diet induces biliary epithelial cell proliferation and suggests this may account for the so-called ductular reaction in advanced fatty liver disease. Convincing data support the finding that E2f1 is required for BEC proliferation in mice fed with HFD, and organoid models indicate that lipid abundance promotes glycolysis in an E2F-dependent manner.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.81926.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Tontonoz</surname><given-names>Peter</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/046rm7j60</institution-id><institution>University of California, Los Angeles</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.07.26.501569">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2022.07.26.501569v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Hepatic lipid overload potentiates biliary epithelial cell activation via E2Fs&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Carlos Isales as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1. Epcam+ cells can differentiate into different parts of the biliary tree, it should therefore be clarified which biliary identity the investigated organoids adopt during the differentiation to relate it to the in vivo data.</p><p>2. Gene expression profiling, instead of 4 transcripts in Figure 1E-F, of BEC-organoids after FA treatment may uncover broader transcriptional programs. One would expect E2F-driven transcriptional programs to be increased. One would also expect more cholangiocyte-specific markers as opposed to hepatocyte-specific markers for this BEC-organoid model.</p><p>3. The authors relate the presented transcriptional and metabolic changes to the initial and early stage of BEC activation associated with NAFLD, however, do not provide a detailed characterization of whether the results shown correspond to the early or late stage of DR. Related to this, while Ncam1 is known to be upregulated in activated BECs, is the level of upregulation similar to in vivo and generally the authors should provide a more complete molecular characterization of the DR signature to support this point.</p><p>4. Figure 1H would be strengthened with a quantitative method to assess lipid accumulation within liver-derived BECs, such as performing Epcam+ BEC FACS isolation from HFD-fed mice followed by BODIPY staining and analysis by flow cytometry.</p><p>5. The authors state that lipid overload is sufficient to initiate DR without epithelial damage. While indeed no cell death is observed, the authors do not provide any analysis of the consequences of high fatty acid treatment on the biliary epithelium. In Figure 1, the nuclear pattern of FA-treated organoids differs from those in controls. Likewise, the PANCK immunostaining of livers from mice after 15 weeks of HFD seems to indicate that the bile ducts have at least partially lost their epithelial organization. Please clarify possible changes to the epithelium and how this relates to the stage of DR.</p><p>6. In Figure 3D-F, similar to in Figure 2C-D, the majority of bile ducts have 0 proliferating cells. A quantitative method as mentioned above would strengthen these findings. Performing EDU staining as done in Figure 2E would also be more convincing.</p><p>7. Given that a full knock-out is used to test the E2F1 requirement, it should be addressed whether a non-autonomous role for hepatocytes in BEC activation can be excluded. Moreover, the authors could use this experimental condition to assess the role of the other three E2Fs, which they identified in the transcriptome analysis. Are they upregulated in the HFD condition, if so, what can be concluded about their function?</p><p>8. For the experiments shown in Figure 4C, it should be clarified why organoids from HFD BECs are dissociated with the aim to again form organoids in the presence of an FA mix. Would the results be different, or why can the HFD BEC organoids not be treated directly with the FA mix? Also, does this condition alter the organoid forming potential compared to Fig2H?</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.81926.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1. Epcam+ cells can differentiate into different parts of the biliary tree, it should therefore be clarified which biliary identity the investigated organoids adopt during the differentiation to relate it to the in vivo data.</p></disp-quote><p>In our study, we followed a well-established protocol to culture biliary epithelial cell (BEC)derived organoids that recapitulates BEC activation, in vitro, and allows the clonal and longterm expansion of EPCAM<sup>+</sup> biliary cells as self-renewing bi-potent progenitors. These cells are capable of differentiating into biliary- or hepatocyte-like cells in vitro<italic>,</italic> when cultured in specific differentiation media, and in vivo, following transplantation (Huch M. <italic>et al.</italic>, Nature, 2013; Huch M. <italic>et al.</italic>, Cell, 2015; Li B. <italic>et al.</italic>, Stem Cell Reports, 2017; Tarlow B.D. <italic>et al.</italic>, Hepatology, 2014; Dorrel C. <italic>et al.</italic>, Genes and Development, 2013; Aloia L. <italic>et al.</italic>, Nature Cell Biology, 2019). In the absence of specific differentiation factors, these BEC organoids remain undifferentiated and proliferate, mimicking the regenerative response coordinated by reactive BECs (Aloia L. <italic>et al.</italic>, Nature Cell Biology, 2019). In this respect, the identity of these undifferentiated BEC-organoids has been systematically characterized by Clever’s laboratory and compared with primary hepatocytes, hepatocyte-organoids (Hu H. <italic>et al.</italic>, Cell, 2018), and differentiated BEC-organoids (Huch M. <italic>et al.</italic>, Nature, 2013). Moreover, Jan Tchorz's laboratory has further demonstrated that these undifferentiated BEC-organoids have a biliary gene signature (Planas-Paz L. <italic>et al.</italic>, Cell Stem Cell, 2019).</p><p>As the main objective of our current study was to characterize the biological behavior of progenitor cells in response to chronic fatty acid load, we only used undifferentiated organoids displaying a biliary gene signature and a marked proliferative capacity. We apologize if this was not sufficiently clear in the first version of our manuscript, and we have now further specified this point in the text (page 4, lines 73-77).</p><p>Furthermore, to rule out the possibility that the HFD might induce spontaneous differentiation in vivo and in vitro, we have identified several markers from the literature for hepatocytes and BECs (Planas-Paz L. <italic>et al.</italic>, Cell Stem Cell, 2019). We then investigated these genes in our samples, such as EPCAM<sup>+</sup> cells isolated from CD- and HFD-fed mice livers (<xref ref-type="fig" rid="sa2fig1">Author response image 1A</xref>) and their organoid cultures (<xref ref-type="fig" rid="sa2fig1">Author response image 1B</xref>), and confirmed that the diet had no impact on the identity of these cells, which kept their bipotent progenitor phenotype.</p><fig id="sa2fig1" position="float"><label>Author response image 1.</label><caption><title>Heatmaps representing the expression of hepatocyte and BEC markers in EPCAM<sup>+</sup> BECs isolated from livers of C57BL/6J mice fed with CD or HFD for 15 weeks (A) and BEC-organoids derived from the cells described in A (B).</title><p>Heatmaps represent the Z-score calculated as “-1 * Z-score” from the expression data from RNAseq (A) and the δ CT values from RT-qPCR (B), respectively. <italic>36b4</italic> was used as the housekeeping gene..</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81926-sa2-fig1-v2.tif"/></fig><disp-quote content-type="editor-comment"><p>2. Gene expression profiling, instead of 4 transcripts in Figure 1E-F, of BEC-organoids after FA treatment may uncover broader transcriptional programs. One would expect E2F-driven transcriptional programs to be increased. One would also expect more cholangiocyte-specific markers as opposed to hepatocyte-specific markers for this BEC-organoid model.</p></disp-quote><p>We fully agree with the reviewer that a broad analysis could unveil important information. However, as the scope of Figure 1 was to provide proof of concept that BECs can respond to lipid overload by adapting their cellular metabolism, we only monitored four well-established markers of lipid metabolism known to be activated upon metabolic challenge (Figures 1E and 1F). We opted to perform the more unbiased transcriptomics approach in the in vivo setting, in particular on chronically exposed BECs in HFD-fed mice, to avoid possible confounding factors induced by in vitro growth (e.g., growth factors and glucose-enriched cell culture medium that supports continuous expansion, the intrinsic over-proliferative state of the in vitro organoid culture). As a result, we found E2Fs as a candidate transcription factor family. We strongly believe that this approach is more meaningful as it reflects the in vivo HFD-induced changes in BECs.</p><disp-quote content-type="editor-comment"><p>3. The authors relate the presented transcriptional and metabolic changes to the initial and early stage of BEC activation associated with NAFLD, however, do not provide a detailed characterization of whether the results shown correspond to the early or late stage of DR. Related to this, while Ncam1 is known to be upregulated in activated BECs, is the level of upregulation similar to in vivo and generally the authors should provide a more complete molecular characterization of the DR signature to support this point.</p></disp-quote><p>We thank the reviewers for this relevant comment. To characterize the stage of the DR in our experimental setup, we consulted Dr. Christine Gopfert, an expert pathologist at EPFL, for a blinded analysis of liver sections from CD- and HFD-fed mice. In line with previous HFD studies conducted in C57BL/6J mice (Hebbard L. <italic>et al.</italic>, Nature Reviews Gastroenterology and Hepatology, 2010; Febbraio M.A. <italic>et al.</italic>, Cell Metabolism, 2019; Giles D.A. <italic>et al.</italic>, Nature Medicine, 2017), the histopathological features of the HFD livers were limited to steatosis and inflammation, without any notable detection of fibrosis (Picrosirius red staining) in the portal areas (New Figure 1 —figure supplement 1E, page 6, lines 109-111). In addition, the architecture of bile ducts (pan-cytokeratin (PANCK) and osteopontin (OPN) immunohistochemistry) was similar in CD and HFD livers (New Figure 1 —figure supplement 1I, page 6, lines 111-114), which is consistent with the lack of portal fibrosis and inflammation. These findings strongly suggest that HFD is sufficient to prime the reprogramming of a subset of BECs to a “progenitor” state, a well-known early step in BEC activation and an important prerequisite for installing the DR response later on. Based on this evidence and on the fact that the expression of established DR markers does not change in our RNA sequencing data of EPCAM<sup>+</sup> cells isolated from CD and HFD-fed mice livers (New Figure 2 —figure supplement 1E, page 7, lines 129-133), we conclude that HFD feeding triggers the plastic conversion of quiescent BECs into proliferative progenitors but is insufficient to support a complete DR response, which requires more parenchymal damage and inflammation. To avoid confusion and to be consistent with the literature, we refer to this event as “BEC activation” and to proliferating BECs as “reactive BECs” (Glaser S.S. <italic>et al.</italic>, Expert Reviews in Molecular Medicine, 2009).</p><disp-quote content-type="editor-comment"><p>4. Figure 1H would be strengthened with a quantitative method to assess lipid accumulation within liver-derived BECs, such as performing Epcam+ BEC FACS isolation from HFD-fed mice followed by BODIPY staining and analysis by flow cytometry.</p></disp-quote><p>We thank the reviewers for this helpful suggestion. We used several approaches described below to clarify and improve this crucial point in our manuscript.</p><p>i) We acquired new images from liver sections of C57BL/6J mice fed CD or HFD for 15 weeks using a confocal microscope to show more precisely the localization of BODIPY (lipid staining) signal in the PANCK (bile duct marker) positive cells and replaced the images in the first version of our manuscript with the new ones (New Figure 1H).</p><p>ii) We performed a new in vivo experiment to quantify the number of EPCAM<sup>+</sup> BECs that accumulated lipids (BODIPY<sup>+</sup>) in livers from C57BL/6J mice after 15 weeks of CD or HFD feeding. We designed and tested a new FACS analysis protocol and, using the gating strategy illustrated in New Figure 1 —figure supplement 1L and New Figure 1I, we confirmed that EPCAM<sup>+</sup> BECs accumulate more lipids after HFD feeding (New Figure 1I, pages 6-7, lines 114-117).</p><p>Overall, these new data confirm and significantly strengthen our findings, formally demonstrating, in vivo, that BECs efficiently accumulate lipids upon chronic fat overload.</p><disp-quote content-type="editor-comment"><p>5. The authors state that lipid overload is sufficient to initiate DR without epithelial damage. While indeed no cell death is observed, the authors do not provide any analysis of the consequences of high fatty acid treatment on the biliary epithelium. In Figure 1, the nuclear pattern of FA-treated organoids differs from those in controls. Likewise, the PANCK immunostaining of livers from mice after 15 weeks of HFD seems to indicate that the bile ducts have at least partially lost their epithelial organization. Please clarify possible changes to the epithelium and how this relates to the stage of DR.</p></disp-quote><p>We thank the reviewers for raising these points. To address the comment about the nuclear pattern, we re-analyzed our in vitro findings and acquired supplementary images of the organoids treated with the FA mix. These additional studies clearly demonstrate that there is no change in nuclear morphology (New Figure 1B). The lack of epithelial reorganization was furthermore confirmed in vivo by the pathologist, who did not find any morphological difference in the epithelial structure of the bile ducts of HFD-fed mice (see point 3 above). These observations are fully in line with our previous findings that chronic lipid exposure triggers increased proliferation without necessarily invading the portal plate of the parenchyma. As we noticed that the term “early DR” might raise confusion (see point 3), we decided to rephrase this process as “BEC activation” instead of “early DR”. By using this new description, we hope that we have eliminated any possible confusion linked to the broader definition of the DR.</p><disp-quote content-type="editor-comment"><p>6. In Figure 3D-F, similar to in Figure 2C-D, the majority of bile ducts have 0 proliferating cells. A quantitative method as mentioned above would strengthen these findings. Performing EDU staining as done in Figure 2E would also be more convincing.</p></disp-quote><p>We thank the reviewers for this insightful comment. We would like to point out that the low number of proliferating BECs in the healthy unchallenged liver is in line with the literature (Aloia L. <italic>et al.</italic>, Nature Cell Biology, 2019). On the other hand, we understand the reviewer's concern about the specificity of immunofluorescence quantifications and the request to repeat this experiment in a more quantitative manner. To this end, we optimized a new protocol and quantified proliferative EdU<sup>+</sup> BEC cells by FACS in a new cohort of C57BL/6J mice fed CD or HFD. These FACS data, now included in the revised manuscript (New Figure 2G, page 8, lines 145-149), confirm our previous immunofluorescence quantifications. Unfortunately, we were not able to repeat this experiment in the <italic>E2f1</italic><sup>+/+</sup> and <italic>E2f1</italic><sup>-/-</sup> mice, as our collaborators no longer had this strain in their animal facility. Despite this unforeseen event, we hope that the reviewers appreciate the new set of quantifications that further substantiate the pro-proliferative effect of long-term HFD on BECs.</p><disp-quote content-type="editor-comment"><p>7. Given that a full knock-out is used to test the E2F1 requirement, it should be addressed whether a non-autonomous role for hepatocytes in BEC activation can be excluded. Moreover, the authors could use this experimental condition to assess the role of the other three E2Fs, which they identified in the transcriptome analysis. Are they upregulated in the HFD condition, if so, what can be concluded about their function?</p></disp-quote><p>We thank the reviewers for this insightful comment. To rule out a non-autonomous role of hepatocytes in BEC activation, we transiently knocked down E2F1 in EPCAM<sup>+</sup> BECs sorted from livers of C57BL/6J HFD-fed mice by transfecting E2F1-specific siRNAs (SMARTpool mix, Horizon) (New Figure 3 —figure supplement 1D) and then assessed their effect on organoid expansion. As expected, compared to scrambled siRNA, silencing of E2F1 significantly reduced the proliferation of EPCAM<sup>+</sup> BECs (New Figure 3 —figure supplement 1E, page 10, lines 186-188), confirming that E2F1 is an essential driver of BEC activation and that this effect is cell-autonomous. We believe this experiment strengthens our initial hypothesis that E2F1 drives BECs proliferation upon HFD feeding. We agree with the reviewers that a systematic dissection of the E2F protein family could further tease out the mechanistic basis. However, these investigations go beyond the scope of the current study and will be the focus of future work in the lab.</p><disp-quote content-type="editor-comment"><p>8. For the experiments shown in Figure 4C, it should be clarified why organoids from HFD BECs are dissociated with the aim to again form organoids in the presence of an FA mix. Would the results be different, or why can the HFD BEC organoids not be treated directly with the FA mix? Also, does this condition alter the organoid forming potential compared to Fig2H?</p></disp-quote><p>We thank the reviewers for allowing us to clarify this point. In Figure 2H, we used organoid forming capacity as a proxy for BEC “progenitor activation” in vivo. To this end, we seeded equal numbers of cells from digested livers of CD- and HFD-fed mice and showed that the increased EdU signal observed after HFD (New Figure 2G) coincides with an increased ability to form organoids (Figures 2H and 2I), indicating that long-term fat exposure in vivo is sufficient to trigger “progenitor activation”. Given the aim of this experiment, we believe that the colony-forming assay of FA-treated expanding progenitors would not be informative. The metabolic investigation (Figure 4C) requires a high number of cells. For this reason, we amplified BEC-organoids after their derivation using the traditional method mentioned above (isolating single cells from digested livers and allowing BECs to expand in vitro as organoids). After expansion, these organoids were digested into single cells, counted, and equal cell numbers were then reseeded into 48-well plates to perform standardized and controlled Seahorse experiments. We hope this information justifies the different protocols used in Figures 2 and 4.</p></body></sub-article></article>